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ABSTRACT OF THESIS 
 
 
EFFECTS OF FEEDING A YEAST-BASED SUPPLEMENT CONTAINING 
DOCOSAHEXAENOIC ACID (DHA) FROM A HETEROTROPHICALLY GROWN 
MICROALGAE, VITAMIN E, AND SELENIUM ON STALLION SPERM MOTION 
CHARACTERISTICS 
 
The use of cooled and frozen stallion semen has become quite popular. However, there 
are some stallions that have sperm that are quite susceptible to cold shock. Thus, there is 
a need for techniques that will alter sperm so that they can withstand the stresses of 
cooling and freezing and thus improve pregnancy rates achieved with cooled or frozen 
spermatozoa. Studies have shown that a diet high in omega-3 (n-3) fatty acids can 
improve the motility of cooled and frozen/thawed sperm. Many of the omega-3 fatty acid 
products for stallions have low levels of docosahexaenoic acid (DHA) and are based on 
fish oil, which may have reduced palatability. The objectives of this study were to 
determine if a yeast-based supplement containing 15g DHA from a heterotrophically 
grown microalgae, 1000 IU Vitamin E and 2mg selenium as selenized yeast would 
enhance the motility of fresh, cooled, and frozen-thawed stallion sperm. Twelve stallions, 
3 to 12 y old were used. Semen was collected every other day for two weeks (July) and 
sperm motion parameters (total and progressive motility) were determined by computer 
assisted sperm analysis (CASA) on the last three ejaculates. These ejaculates were cooled 
to 5°C (Equitainer, Hamilton Thorne) and held for 48 hr. Stallions were then paired based 
on CASA values for fresh and cooled semen, age of stallion, sperm output and body 
condition and randomly assigned to either control or treatment. Stallions were fed one of 
two dietary treatments for 60 d: A basal diet, Control, 0.4% BW as concentrate and 1.8% 
BW as grass hay, and Treated, basal diet plus 160g of a yeast-based supplement 
containing 15g DHA from a heterotrophically grown microalgae, 1000 IU Vitamin E and 
2mg selenium as selenized yeast (Alltech Inc., Nicholasville, KY). Consumption of the 
supplement was accepted within a few days of feeding. Beginning on day 46, stallions 
had semen collected every other day until day 60. Sperm motion parameters were 
assessed with CASA. For cryopreservation, sperm were loaded into 0.5-mL straws and 
frozen with a programmable freezer. Using flow cytometric analysis, sperm viability, 
mitochondrial membrane potential, lipid peroxidation, acrosomal status, and membrane 
fluidity were measured on frozen-thawed sperm. Sperm viability was measured using 
both a SYBR-14/PI stain as well as a Yo-Pro+/PI- stain. Sperm mitochondrial membrane 
potential was evaluated using JC-1, and lipid peroxidation measured using BODIPY 
581/591 C11. Acrosomal status was analyzed using FITC-PNA/PI and membrane fluidity 
evaluated using Merocyanine 540/Yo-Pro. Data was analyzed using a mixed model and 
significance was set to p ≤ 0.05. Although a significant improvement in total and 
progressive motility was seen in both the fresh and the cooled spermatozoa in sperm from 
the DHA/Vit E/Sel treated stallions, there was no significant difference noted at any of 
the parameters measured in the frozen-thawed sperm. An oxidative challenge experiment 
was also conducted in which frozen-thawed sperm were deliberately stressed with FeCl2 
and H2O2. To evaluate the effects of the oxidative challenge, a matched pairs analysis 
was used. To analyze differences in the way that sperm from control stallions and 
DHA/Vit E/Sel treated stallions handled the oxidative stress imposed upon them, a one-
way ANOVA was used to compare the percent increase in positive (oxidative stressed) 
cells. Results for the oxidative challenge study proved that treatment with the FeCl2 and 
H2O2 oxidative challenge was effective at inducing oxidative stress to the sperm 
membrane in both control and DHA/Vit E/Sel treated stallions, however no significant 
difference was seen in the way that control versus treated stallion sperm withstood the 
oxidative challenge.  
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Chapter One: Introduction 
 
Equine breeding is a multi-billion dollar industry encompassing many different 
breeds and disciplines. In competitive industries, the breeding fees of stallions can range 
from a couple hundred dollars to hundreds of thousands of dollars for insemination and 
confirmed pregnancy of a mare. The majority of equine breeding industries utilize 
artificial insemination (AI) for impregnating mares, due to its efficiency and 
effectiveness. Artificial insemination is becoming an increasingly popular tool in the 
advancement of breeding and genetics in both the equine industry and the agricultural 
industry as a whole [1].  
The only major equine breed registry that does not allow AI is the Jockey Club 
for Thoroughbreds. However, Quarter Horses (QH) make up over 60% of all registered 
horses in the United States, and for many years the QH industry has allowed the use of AI 
with fresh semen, as well as with cooled and frozen semen. Unfortunately, the viability 
and fertilization capability of spermatozoa decreases with cooling and freezing. This is 
due in part to the lipid peroxidation cascade and generation of reactive oxygen species 
(ROS), which cause the level of polyunsaturated fatty acids (PUFAs), especially 
docosahexaenoic acid, to decrease significantly, contributing to a loss of sperm quality 
and a resulting decrease in fertility [2]. There is a need to enhance the fertility of cooled 
and cryopreserved spermatozoa in order to maintain high fertility rates after the freezing 
and thawing process. Successful semen cryopreservation is necessary in order to further 
enhance the advantages of AI. Cryopreserved semen is able to be stored long-term and 
can be transported long distances and used for an extended period of time, which is 
especially useful after the death of a genetically superior sire [1]. Ultimately, there is the 
need for a product that will alter spermatozoa so that they are better able to withstand the 
stresses of cooling and freezing, with the goal of improving pregnancy rates.  
Unfortunately, out of many of the products tested to potentially remove the 
irreversible damage that is induced by cryopreservation, few have been very promising. 
The major fatty acid in the stallion sperm plasma membrane is docosahexaenoic acid 
(DHA) [3]. DHA (C22:6 n-3)  is an omega-3 polyunsaturated fatty acid (PUFA) with 22 
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carbons and 6 cis double bonds. It is the longest chain and most unsaturated fatty acid 
found commonly in biological systems, making it possibly the most influential of the 
omega-3 group of polyunsaturated fatty acids [4,5]. Studies have shown that feeding fish 
oil that is high in DHA content improves sperm motility, viability, and acrosomal 
integrity in men [6], bulls [7,8] [9], boars, and rats [10].   
However, the number of studies in stallions has been limited. In a 2005 study by 
Brinsko et al., feeding a supplement high in DHA to stallions for 14 weeks increased 
motility and the percentage of rapidly motile sperm after 48 hours of cooling and storage 
at 5 °C [11]. Post-thaw sperm motility of frozen semen tended to increase for those 
stallions that were supplemented with DHA [11]. Brinsko et al. noted that there may have 
been an even further increase in semen parameters had they added other ingredients to the 
ration, as it has been demonstrated that the response to the feeding of omega-3 fatty acids 
is dependent upon the ratio of omega-3 to omega-6 fatty acids, and a diet high in cereal 
grains is rich in omega-6 fatty acids. In a similar study (Squires, unpublished), stallions 
fed 15 g of DHA had increased sperm motility in fresh semen as well as in sperm that 
were cooled for 24 hours at 5 °C. The authors suspected that the improvement in semen 
parameters might have been even more improved if the DHA ration had also contained 
antioxidants, such as vitamin E and selenium. Both above studies demonstrated that DHA 
was in fact incorporated into the sperm membrane, and thus theoretically could be used to 
alter the stallion sperm to better withstand the stresses of cooling and freezing.  
Therefore, more studies are needed to increase knowledge and to optimize the 
beneficial effects of omega-3 fatty acids when fed to stallions. These studies may include 
altering DHA levels in the supplement, minimizing the amount of omega-6 fatty acids in 
the diet, and adding antioxidants to the DHA-containing product. In the diet of boars, the 
addition of DHA and L-cysteine increased post-thaw motility, viability, and acrosomal 
integrity of cryopreserved spermatozoa [9]. In bull sperm, the combination of omega-3 
fatty acids and vitamin E changed the sperm membrane composition and improved the 
freezability of sperm [8].  Adding selenium as an antioxidant may also be beneficial to 
spermatozoa when given in combination with DHA, as the selenium content of equine 
spermatozoa has been found to positively correlate with progressive motility and fertility 
rate [12].  
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Differences in fatty acid composition of the sperm plasma membrane have been 
shown to be involved in defective human spermatozoa [13]. Also in humans, the amount 
of DHA in sperm membranes has been shown to be positively correlated with progressive 
motility, and lower levels of DHA were seen in the sperm of infertile men as compared to 
fertile men [14]. In pigs, supplementation with n-3 fatty acids increased both sperm 
quality [15] and sperm numbers [16]. There has been some evidence that feeding fish oil 
to boars increases DHA in the testis and increases steroid production [17], and these 
alterations demonstrate the potential to affect sperm production. It has also been shown 
that feeding fish oil to rams helped curb the seasonal decline in sperm production and 
semen quality [18]. Studies in the stallion are lacking, but it may be possible that infertile 
or sub-fertile stallions have lower levels of DHA in their sperm, and that those stallions 
that have semen that cools or freezes poorly also have reduced levels of DHA in their 
sperm.  
Many of the products currently on the market with supposed benefits to semen 
parameters in stallions do not contain sufficient levels of the appropriate omega-3 fatty 
acids or antioxidants, and are generally not very palatable. Thus, there is the need for a 
product that is both palatable and contains high levels of DHA and antioxidants.  
The objectives of our initial study were to determine if a yeast-based supplement 
containing 15g DHA from a heterotrophically grown microalgae, 1000 IU vitamin E, and 
2mg selenium as selenized yeast would enhance the motility of stallion sperm in fresh, 
24- and 48-hour cooled, and frozen semen. We also evaluated the effects of this 
supplement on frozen-thawed sperm viability, mitochondrial membrane potential, lipid 
peroxidation, acrosomal status, and membrane fluidity. We then analyzed additional 
frozen semen with the intention of viewing differences between control and DHA-treated 
frozen/thawed sperm samples in their ability to withstand oxidative stress.  
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Chapter Two: Literature Review 
2.1  Lipid Composition of Stallion Sperm Membranes  
 
The lipid bilayer is the main barrier to the external environment in almost all living 
cells, and is responsible for keeping molecules from diffusing inappropriately into or out 
of the cell. The bilayer is a membrane made up of two layers of phospholipid molecules, 
with polar hydrophilic heads and hydrophobic tails. The main components of the polar 
phospholipids have been shown to be highly polyunsaturated fatty acids (PUFAs) [19]. In 
sperm, the major phospholipid classes are choline and ethanolamine phosphoglycerides 
[20]. The phospholipid-bound fatty acyl compositions of choline and ethanolamine 
phosphoglycerides are characterized by a high proportion of docosapentanoyl and 
docosahexanoyl groups in mammalian sperm [20]. Proteins, cholesterol, glycolipids, and 
other molecules are inserted into the lipid bilayer in a specific manner to provide 
functionality for a particular cell [21]. The fatty acid composition of cell membranes 
regulates the activities of different lipid-dependent membrane-bound enzymes and the 
membrane resistance to both physical and chemical stresses [13]. Sperm membranes 
differ from the typical lipid bilayer membrane in that they have high levels of ether-
linked lipids and a high concentration of unsaturated fatty acyl groups such as 
docosahexaenoyl chains [22]. Sphingomyelins are also a major lipid component of sperm 
membranes [22]. Although these molecules do not have an unusual amount of 
glycolipids, they do contain a structure that is unique to sperm: 
sulfogalactosylglycerolipid, or seminolipid [22].  
Cholesterol is the major sterol comprising the plasma membrane of most animal cells, 
and its primary role is to modulate the physical properties of membranes [23]. 
Cholesterol has been found to be the primary sterol in boar, bull, stallion, and rooster 
sperm membranes [20]. The membrane structure of spermatozoa plays a critical role in 
the fertilization process, and sperm lipids have been suggested to be important for the 
viability, maturity, and normal functions of sperm [13]. Acrosomal responsiveness and 
fertilizing ability in vitro are affected by the cholesterol content of sperm [24]. The ratio 
of cholesterol to phospholipid in sperm membranes is around 1:1; this high cholesterol 
content seems to play an important role in sperm capacitation [24]. 
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 The capacitation state of the sperm is determined by the cholesterol to phospholipid 
(C/PL) ratio in the sperm membrane [22]. During capacitation, cholesterol exchanges 
places with phospholipids, with cholesterol moving to protein acceptors and 
phospholipids migrating into the sperm membrane [22]. The C/PL ratio is high in freshly 
ejaculated sperm, however this ratio is altered during the capacitation process [22]. 
Normal sperm possess a higher percentage of PUFAs than that of other cell membranes 
[25]. Differences in fatty acid composition of the sperm plasma membrane have been 
shown to be involved in defective human spermatozoa [13]; however few studies on the 
lipid composition of stallion spermatozoa exist.  
PUFAs are believed to give the sperm plasma membrane the flexibility and fluidity it 
requires for normal cell functions, such as membrane fusion with an oocyte during 
fertilization [25-27]. The proportion of unsaturated fatty acids to saturated fatty acids 
may have an influence on the physical properties of the sperm membrane, including 
membrane fluidity [28]. Interestingly, the high percentage of PUFAs that has been 
documented in human and other mammalian spermatozoa has been shown to vary 
significantly depending on the type of diet, and in animals, on the season of the year [25].  
After the sperm has matured completely in the epididymis, sperm membranes possess 
a specific composition of phospholipids and a very high concentration of polyunsaturated 
fatty acids [25]. PUFAs are the precursors of prostaglandins and leukotrienes, which are 
important in sperm motility [13]. PUFAs also promote the activity of key enzymes, such 
as the plasma membrane ATPases [29], and regulate Ca2+ channels, suggesting a role in 
cell signaling [30, 31]. The sterol content of both rat and equine sperm plasma 
membranes has been shown to decrease as sperm move through the epididymis [32, 33]. 
The composition of stallion sperm membranes includes many different lipid classes, acyl 
chain lengths, and saturation levels [20, 34]. In stallion sperm it has been demonstrated 
that saturated fatty acids, which are negatively correlated with live sperm, are the main 
components of the neutral lipids of the sperm plasma membrane [19]. Higher saturation 
of the phospholipids of the sperm cell membrane is associated with poor sperm quality 
[19]. 
In rats fed an essential fatty acid-deficient diet, decreased concentrations of PUFAs 
caused a degeneration of the seminiferous tubules, a progressive decrease in germinal 
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cells, and an absence of spermatozoa in the lumina of the seminiferous tubules and 
epididymis [35]. These alterations cause subsequent infertility related to the reduction in 
the proportion of arachidonic acid in the total fatty acid content of the testis [35]. The 
underlying reason for the susceptibility of spermatozoa to oxidative stress is due to its 
membrane composition. Due to the fact that mammalian spermatozoal membranes are 
composed largely of PUFAs [36], primarily docosahexaenoic acid (DHA) [37-41] which 
are very sensitive to oxygen-induced damage mediated by lipid peroxidation. DHA is 
especially susceptible to oxidation due to its six double bonds [4]. 
PUFAs and cholesterol are the main targets for free radical damage, and an inverse 
relationship between lipid peroxides and sperm motility has been clearly documented 
[42]. The high polyunsaturated fatty acid content of sperm makes them susceptible to 
damage from peroxidation [19, 36], which adversely affects motility, metabolism, 
structure, and fertility by way of membrane damage, inhibition of respiration, and 
leakage of intracellular enzymes [43]. Therefore, their degree of unsaturation is an 
essential parameter in the ability of spermatozoa to maintain equilibrium in an oxidative 
environment [25]. Even though polyunsaturated fatty acids are particularly sensitive to 
lipid peroxidation, they also demonstrate antioxidant properties which help the sperm 
membrane remain intact under stressful conditions [19].  
It is possible that the typical equine diet, which is often high in cereal grains, may 
have negative consequences on stallion spermatozoa due to the fact that cereal grains 
generally contain high levels of omega-6 fatty acids. A negative correlation has been 
established between increased omega-6 fatty acid content and normal sperm parameters 
in human males [44]. This negative correlation between increased saturated fatty acid 
content and sperm parameters has also been reported in infertile boars [45]. In humans, 
higher omega-6 to omega-3 ratios in the sperm of infertile versus fertile men, 
respectively, has been demonstrated [13]. 
 
2.2  Docosahexaenoic Acid (DHA) 
 
Polyunsaturated fatty acids (PUFAs) are fatty acids that contain one or more carbon-
carbon double bonds. Different types of PUFAs include the omega-3 fatty acids, 
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including docosahexaenoic acid (DHA), the omega-6 fatty acids, such as linoleic acid, 
and omega-9 fatty acids such as eicosenoic acid. The first carbon of the methyl group in a 
fatty acid is called omega in the omega system and based on the distance of other carbons 
from omega; the fatty acid is called an omega-3, omega-6, or omega-9 fatty acid [46]. 
There are also conjugated polyunsaturated fatty acids containing two or more conjugated 
double bonds. The different classes of PUFAs include the essential fatty acids that 
humans and other animals require to survive, but have to ingest in the diet due to the 
body’s inability to synthesize them on its own. One of these essential fatty acids is α-
linoleic acid, found in green grass and vegetables, which can be converted to DHA in 
small amounts [47]. 
DHA (C22:6 n-3) is an omega-3 polyunsaturated fatty acid with 22 carbons and 6 
double bonds. It is the longest chain and most unsaturated fatty acid found commonly in 
biological systems, making it possibly the most influential of the omega-3 group of 
polyunsaturated fatty acids [4, 5]. To be specific, an omega-3 PUFA is an omega-3 fatty 
acid with a double bond (C=C) at the third Carbon atom from the methyl end of the 
Carbon chain. In most mammalian sperm, docosahexaenoic acid is the predominant fatty 
acid, although some studies have demonstrated that in stallions the n-6 fatty acid 
docosapentanoic acid predominates [19].  
DHA is obtained in the diet through consumption of seafood; however in animals that 
do not consume seafood, DHA can also be internally manufactured from α-linoleic acid 
[29], which is found in the chloroplasts of green grass and vegetables. However, very 
little natural conversion actually occurs, so it can be necessary to feed a marine-based 
supplement in order to increase internal DHA concentration. Once consumed, DHA can 
be rapidly taken up into cells and incorporated into membrane phospholipids [5]. In 
tissues that do not contain high levels of DHA, that being less than 5 mol%, DHA levels 
can be increased very significantly through consumption [48-50], although incorporation 
of DHA into phospholipids does vary with tissue type [5].  
DHA has been demonstrated to significantly alter many basic properties of 
membranes including fluidity, which in sperm tails is necessary for motility [51], as well 
as phase behavior, permeability, and protein activity, among others [4]. It has also been 
proven to affect hormone (eicosanoid) production [52], formation of lipid peroxidation 
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products [53], conformation and activity of enzymes [54], transcription events [55], and 
membrane structure and function [4, 56]. DHA is believed to be acting at a fundamental 
level relating to the high degree of conformational flexibility that its multiple double 
bonds confer, since it appears to affect so many different biological systems [4, 56]. The 
mechanism of action of DHA is not entirely clear, and it is likely multifaceted [5].  
The addition of acyl chain double bonds to a molecule is generally assumed to 
increase fluidity—Therefore it can be postulated that a membrane rich in DHA should be 
exceptionally fluid [4], a theory which should help to support the idea that 
supplementation of DHA could help improve sperm membranes and ultimately increase 
male fertility.  Many dietary studies have reported increases in membrane fluidity from 
animals fed DHA-rich fish oil diets [57, 58] and also in cells cultured in DHA-rich media 
[59-62]. It is believed that DHA may play a significant role in membrane lateral domain 
structure, although the mechanism by which DHA incorporates into different 
phospholipids remains unclear [5]. However, it is known that once DHA is incorporated 
into cell membranes, it is exposed to cholesterol, and the interaction between these two 
species likely affects membrane structure and function [23]. DHA’s aversion to 
cholesterol causes a separation between the DHA-containing phospholipids and 
cholesterol, creating a phase separation into DHA-rich, cholesterol-poor domains and 
DHA-poor, cholesterol-rich domains [5]. The high discrepancies between these two 
created domains alters membrane location of signaling proteins and thus modulates 
cellular functions [5]. A fair generalization could be made by the assumption that 
membranes whose lipids are poorly packed should also be highly permeable, and 
multiple studies have connected DHA to an increase in membrane permeability [5]. 
DHA-containing phospholipids are loosely packed in the membrane; therefore one can 
assume that high levels of these fatty acids may also lead to general membrane instability 
[5].  
In monkeys, 99% of total sperm DHA content can be found in the tail, suggesting that 
DHA density in the sperm tail is likely related to fluidity and flexibility [51]. However, 
additional studies in both humans and bulls reported higher concentrations of total 
omega-3 PUFA content, especially DHA, in the sperm head rather than the tail [40, 64]. 
In mice fed an omega-3 deficient diet, the spermatozoa demonstrated no acrosomal 
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reaction [46]. The percentage of DHA in sperm membranes is higher than in other cells 
[46]. Thus, manipulating sperm head and tail fatty acid profiles by dietary 
supplementation of omega-3 fatty acids may improve sperm function [46], as it is well 
known that the lipid composition of the sperm membrane has a significant effect on the 
functional characteristics of sperm.  
Membranes that are naturally enriched in DHA, such as those of spermatozoa, are 
naturally predisposed to undergo membrane vesicle formation and fusion, such as with an 
oocyte [5]. A study by Garcia et al. in 2011 demonstrated that the percentage of 
docosapentanoic acid (C22:5 n-6), as well as the total percentage of highly 
polyunsaturated fatty acids, were positively correlated with the percentage of live 
spermatozoa in the stallion [19]. Significant negative correlations with LPO were found 
for docosapentanoic acid and total percentage of highly polyunsaturated fatty acids [19]. 
Conversely, the percentages of palmitic acid (C16:0) and total percentage of saturated 
fatty acids were negatively correlated with live, intact stallion sperm [19]. This is 
believed to be because of the fact that polyunsaturated fatty acids increase the fluidity of 
the membrane, whereas long-chain saturated fatty acids increase its rigidity [25]. For 
example, in Garcia et al.’s study in 2011, out of seven stallions, the stallion with the 
poorest sperm quality and highest level of lipid peroxidation had significantly lower 
proportions of docosapentanoic acid in the sperm plasma membrane than the other six 
stallions in the study [19].  
Semen quality can be improved with the supplementation of DHA. Previous studies 
have shown that supplementation of DHA to the diet of stallions increased sperm plasma 
membrane DHA content significantly, and also increased sperm concentration and 
motility, especially in stallions with initially poor sperm motility [11]. Sperm 
concentration in DHA-treated stallions was 1.8 times that of controls, and stallions with 
sperm motility that was less than 40% after 24 hours of cooling showed the most 
dramatic improvement in progressive motility [11]. It was also noted that the levels of 
DHA per billion sperm was three times that of controls [11]. An unpublished study by 
Squires et al. in 2006 noted a tendency for a significant improvement in the total 
percentage of progressively motile sperm per ejaculate at both fresh and 24-hour cooled 
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time points; however they did not note a significant improvement at either the 48-hour or 
post-thaw time points.   
In humans, the amount of DHA in sperm membranes has been shown to be positively 
correlated with progressive motility, and lower levels of DHA were seen in the sperm of 
infertile men as compared to fertile men [14]. In pigs, supplementation with n-3 fatty 
acids increased both sperm quality [15] and sperm numbers [16].  
In 2010, Gholami et al. concluded that feeding a DHA-rich nutriceutical to Holstein 
bulls improved sperm total motility, progressive motility, average path velocity, hypo-
osmotic swelling test (HOST)-positive, and proportion of rapid spermatozoa [7]. This 
study also demonstrated that although semen volume, sperm concentration, and total 
sperm output did not change, the proportion of viable spermatozoa significantly increased 
in the ejaculates of DHA-supplemented bulls as compared to control bulls, and the 
research ultimately concluded that dietary DHA supplementation improved in vitro 
quality and motility parameters of fresh semen [7]. On the other hand, post-thaw sperm 
motility parameters of cryopreserved semen did not significantly differ between control 
and nutriceutical-fed bulls, although the post-thawed sperm velocities (VAP, VSL, and 
VCL) were higher in nutriceutical-fed bulls [7]. No differences in body weight, body 
condition score, or scrotal circumference were seen between control and nutriceutical-
supplemented bulls before and after the treatment period [7].  
In 2010, Kaeoket el al. demonstrated in boar sperm that supplementing the extender 
used during the cryopreservation process with DHA by the addition of fish oil to that 
extender was effective at increasing post-thaw plasma membrane integrity and 
progressive motility [66]. They noted a significantly higher percentage of progressive 
motility, viability, and acrosome integrity in DHA supplemented group than in the 
control group, and that there was a dose-dependent effect of DHA [66].  
Aksoy et al. noted in 2006 that spermatozoa from asthenozoopermic, 
oligozoospermic, and oligoasthenozoospermic men had lower levels of DHA than those 
from normozoospermic men [13]. These data suggest that decreased DHA and PUFA 
may be related to infertility in human males [13]. Lower proportions of DHA and PUFAs 
in the sperm of oligo or asthenozoospermic men may be a result of the breakdown of 
PUFAs due to increases in reactive oxygen species (ROS) [13]. These data as well as 
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others have demonstrated that high concentrations of DHA in both ejaculate and 
spermatozoa are positively correlated with increased sperm motility in humans [13, 40, 
67, 68]. In humans there are significant positive correlations between DHA and PUFAs 
with sperm motility, sperm concentration, and normal sperm morphology [13].   
Many different health benefits have been associated with DHA, such as cancer, heart 
disease, rheumatoid arthritis, and asthma [4], and these benefits may be ascribed to the 
coexistence of DHA-rich domains and lipid rafts in the plasma membrane [69]. DHA has 
been shown to have a positive effect on diseases such as hypertension, arthritis, 
atherosclerosis, depression, adult-onset diabetes mellitus, myocardial infarction, 
thrombosis, and some cancers [70]. In a previous study done in humans, dietary 
supplementation of DHA was shown to have a positive action against atherosclerosis and 
its complications [71]. DHA also decreases blood triglycerides and thrombosis, and helps 
prevent cardiac arrhythmias [70]. Additional studies have reported that DHA-containing 
phospholipids can also buffer the inhibitory effects of cholesterol in the visual receptor-
signaling pathway [72]. Another study on humans has demonstrated the effects of DHA 
on decreasing inflammation, especially the inflammation associated with rheumatoid 
arthritis and asthma [70].  
DHA is also essential for the growth and functional development of the human infant 
brain, and is required for normal brain function in adults [70]. In humans, it often 
comprises about 50% of the membrane acyl chains in retinal and brain tissue [5]. DHA 
deficiencies have been associated with fetal alcohol syndrome, attention deficit 
hyperactivity disorder, cystic fibrosis, phenylketonuria, unipolar depression, aggressive 
hostility, and adrenoleukodystrophy [70], as well as effects on visual acuity and learning 
irregularities [5].   
It is well known that many apoptosis-associated events are linked to membrane 
structure and function [73]; however there is a difference of opinions on the role of DHA 
in apoptosis, as to whether DHA enhances or inhibits apoptosis [5]. Similar to multiple 
other studies, in 2005 Wu et al. reported that DHA caused a significant inhibition of 
breast cancer cell growth and increased apoptosis [74]. In contrast, other reports show 
that DHA inhibits apoptosis, especially on neuronal cells [75-77]. We can therefore 
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deduce that there is a discrepancy between the effects of DHA on neuronal versus other 
cell types [5].  
Ultimately, even though PUFAs are the main target for lipid peroxidation, it has been 
concluded that inadequate DHA concentration is the main cause of low-quality 
spermatozoa [13, 78]. For this reason, the initial study that we performed had the 
intention of increasing DHA-content and therefore improving motion parameters in 
stallion spermatozoa 
 
2.3 Oxidative Stress and Reactive Oxygen Species (ROS) 
 
Oxidative stress is a major factor contributing to male infertility [79] and is 
determined by the balance between the generation and degradation of reactive oxygen 
species within a tissue [80]. Oxidative stress is associated with an increased rate of 
cellular damage induced by oxygen and its derived oxidants, reactive oxygen species 
[81]. ROS are readily detectable in a large percentage of infertile human patients, 
however in fertile patients they are found at very low concentrations [25]. Generation of 
reactive oxygen species in high concentrations can cause sperm damage, resulting in 
decreased motility, deformities, and ultimately impaired fertility. Sperm DNA damage by 
ROS has even been reported to have detrimental effects on post-fertilization development 
[82].  
Spermatozoa and seminal plasma possess different enzymes and antioxidants that 
scavenge ROS to prevent possible cellular damage [80]. There are three major enzyme 
scavenger systems that have been noted in seminal plasma, including the glutathione 
(GSH) peroxidase/reductase system, superoxide dismutase (SOD), and catalase (CAT) 
[80, 81]. Assisted reproductive techniques tend to induce damage to spermatozoa by 
either decreasing the scavenging capabilities of seminal plasma or by increasing ROS 
generation [80]. SOD has been shown to protect spermatozoa against spontaneous 
oxygen toxicity and lipid peroxidation (LPO) [83]. Also, SOD and CAT together remove 
O2
- generated by NADPH oxidase in neutrophils, and may play a role in decreasing LPO 
and protecting spermatozoa during genitourinary inflammation [81]. 
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Antioxidants present in the seminal plasma include Vitamin E, Vitamin C, urate, 
albumin, taurine, and hypotaurine [80]. The total antioxidant capacity of the seminal 
plasma is made up of the enzyme scavengers and the antioxidants themselves [80]. In 
mature spermatozoa, the high concentration of PUFAs is associated with a scarcity of 
these oxyradical scavenger systems such as SOD, CAT, and GSH [25], and this 
deficiency is likely due to the absence of cytoplasm, as most cytoplasmic protective 
enzymes are lost during spermiogenesis [19]. However, this is compensated for by the 
powerful antioxidant system in seminal plasma [25], described above. In vitro, seminal 
plasma significantly decreases the peroxidative damage of free radical generation [25]. In 
vivo, a correlation between SOD in seminal fluid and sperm cell motility has been noted 
[84].  
Excessive generation of ROS induces high levels of LPO, which impairs sperm 
membrane function critical to sperm functionality [85]. Increased ROS generation has 
been shown to result in a marked decline in sperm motility [80]. In humans, exposure of 
spermatozoa to extracellularly generated ROS induces a loss of motility that is directly 
correlated with the level of LPO experienced by the sperm [86]. The rate of fatty acid 
oxidation can vary due to differences in chain length, degree of unsaturation, and position 
and configuration of double bonds [87]. Studies have shown that long chain fatty acids 
are oxidized more slowly, and unsaturated fatty acids are oxidized more rapidly than 
saturated fatty acids [87]. Unsaturated fatty acids are more susceptible to oxidative 
damage than saturated fatty acids due to the fact that they contain one or more double 
bonds, which are prone to oxidation. DHA is an example of a particularly sensitive 
PUFA. The risk of oxidation increases with increasing amounts of double bonds, which is 
why biological membranes, including sperm membranes, containing high concentrations 
of polyunsaturated fatty acids with multiple double bonds, are highly susceptible to 
oxidative damage.  
However, the nuclear DNA in spermatozoa is more resistant to oxidative stress than 
the interphase nuclei of somatic cells, due to its highly compact nature [26]. The 
mitochondrial genome is much more susceptible to DNA damage than the nuclear 
genome [88], therefore, the integrity of the sperm mitochondrial genome is a very 
effective marker of oxidative stress [89]. With the use of quantitative PCR, the nuclear 
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genome of the male gamete can be shown to be very resistant to oxidative damage, as a 
result of the fact that nuclear chromatin is packaged tightly in spermatozoa [90]. But, 
when this sperm chromatin compaction is deficient, extremely high rates of DNA damage 
are seen as a consequence of the stresses imposed by ROS generation [26]. A problem 
with chromatin remodeling during the late stages of spermiogenesis leads to protamine 
deficiencies that put sperm in a vulnerable state, leaving them susceptible to oxidative 
damage when attacked by ROS [26]. Therefore, adequate compaction and stabilization of 
sperm nuclear DNA is critical for protection from oxidative stress [89].  
Interestingly enough, in 2014, Gibb et al. demonstrated a paradoxical relationship 
between stallion fertility and oxidative stress, concluding that spermatozoa from highly 
fertile stallions “live fast and die young” [91]. This study showed a positive correlation 
between stallion fertility and oxidative stress in spermatozoa, revealing that sperm 
samples that produced pregnancies exhibited higher rates of 8-hydroxy-2’-
deoxyguanosine (8OHdG) release, lower vitality, and lower acrosomal integrity than 
those samples that did not produce a pregnancy [91]. The most fertile spermatozoa 
exhibited the highest amounts of oxidative phosphorylation (OXPHOS), where oxidative 
stress was shown to be a by-product of high mitochondrial activity [91]. There were 
positive correlations between mitochondrial ROS generation and total motility, rapid 
motility, average path velocity, and curvilinear velocity; and similarly, lipid peroxidation 
was also positively correlated with these parameters [91]. In other mammals, a positive 
correlation between oxidative stress and sperm functionality has not been observed in this 
manner [91]. This positive correlation between OXPHOS in supporting the motility of 
equine spermatozoa is in contrast with findings in human spermatozoa, which have been 
shown to primarily use glycolysis [91]. The most fertile ejaculates demonstrated the 
highest levels of oxidative stress, therefore there was an inverse relationship between 
fertility and the percentage of viable cells without oxidative damage [91]. Spermatozoa 
from matings that did result in a conception had lower vitality and higher percentage of 
cells with ROS-induced damage than those spermatozoa that did not result in a 
conception, thus supporting the hypothesis that spermatozoa from highly fertile stallions 
do in fact “live fast and die young” [91]. The results of this 2014 study concluded that 
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although the symptoms of oxidative stress are not beneficial to spermatozoa, they might 
indicate a highly fertile sperm sample [91].   
Specifically in the stallion, the changes induced upon spermatozoa during processing 
and storage for preservation adversely affect sperm function and viability due to 
oxidative stress. Important components of this decrease in functionality include damage 
to the chromatin, membranes, and proteins of sperm [92]. Also, the ability of very low 
concentrations of ROS to induce capacitation in equine sperm affects sperm preservation 
[92].  
 
2.4 Essential Roles and Detrimental Effects of Reactive Oxygen Species  
 
ROS are free radical oxidizing agents that contain one or more unpaired electrons, 
thus causing them to be highly reactive [81]. Free radicals have the ability to react with 
many different kinds of biomolecules, including proteins, lipids, and nucleic acids, and 
are likely to be involved in chain reactions which form new free radical products [89]. An 
example of a chain reaction of this sort is the lipid peroxidation cascade, which 
propagates the peroxidative damage throughout the plasma membrane [93].  The most 
common ROS that appear to be implicated in reproductive biology include the superoxide 
(O2
-) anion, hydrogen peroxide (H2O2), peroxyl (ROO
-), and hydroxyl (OH-) radicals 
[81].  
Due to the fact that mammalian sperm are very rich in polyunsaturated fatty acids, 
they are extremely susceptible to ROS attack [81]. This results in decreased sperm 
motility due to a rapid loss of intracellular ATP, thus causing axonemal damage [94], as 
well as a decrease in sperm viability and an increase in sperm morphology defects, which 
thereby contribute to deleterious effects on sperm capacitation and the acrosome reaction 
[81]. The key mechanism promoting this ROS-induced damage to spermatozoa appears 
to be the lipid peroxidation of the sperm plasma membrane [83].   
Production of ROS is normal and believed to be a physiologically important process 
for spermatozoa, playing a role in capacitation, the acrosome reaction, and signaling 
processes that contribute to successful fertilization [26, 79, 95, 96]. The major role of 
ROS in spermatozoa is the regulation of tyrosine phosphorylation, which is a key element 
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in capacitation of mammalian sperm [26]. Sperm capacitation involves a dramatic 
increase in the level of tyrosine phosphorylation. Activation of tyrosine phosphorylation 
in the sperm tail also promotes the induction of hyperactivated motility [26]. Exposure of 
spermatozoa to hyperosmotic conditions also stimulates sperm capacitation [97]. 
Hyperosmotic conditions induce superoxide anion production in both primate and equine 
spermatozoa and stimulate tyrosine phosphorylation [98].  
Normal physiological levels of ROS are crucial to reproductive processes, including 
sperm-oocyte interactions, implantation, and early embryo development [2]. For 
example, hydrogen peroxide has both beneficial and damaging effects on sperm and thus 
influences the fertilization process [81]. Nitric oxide (NO-) also appears to play a role in 
reproduction and fertilization, depending on its concentration and interaction with 
hydrogen peroxide [81]. NO has roles in the vascular system, where it induces 
vasodilation and regulates apoptosis, the nervous system, where NO generated by 
neurons acts as a neurotransmitter, and in the immune system, where it acts as an 
antimicrobial agent [99]. Since the vascular, nervous, and immune systems all play a role 
in regulating both male and female reproductive systems, NO has been established as a 
molecule that plays a role in regulation of these systems [99].  
ROS are generated in the body by various endogenous systems and exposure to 
multiple cellular conditions [100]. Chronic disease states, aging, toxin exposure, and 
physical injury are only a few stress-related conditions that can increase oxidative stress 
and ROS generation [81]. In the human body, ROS have been implicated in over one 
hundred disease states, including arthritis, connective tissue disorders, carcinogenesis, 
infection, and acquired immunodeficiency syndromes [81]. Some of the many conditions 
that can cause ROS generation and oxidative stress to spermatozoa are cryptorchidism, 
testicular torsion, varicocele, hyperthyroidism, diabetes, infection, extreme physical 
exertion, retinoids, and the influence of xenobiotics [101]. Due to the fact that there are 
so many inducers of oxidative stress in the male gonads, there is a strong need for the 
identification of antioxidants that can be supplemented to protect the testes and 
spermatozoa from ROS attack [101].  
The mitochondria are an important source of ROS within most mammalian cells and 
generate them through the respiratory chain [102]. Mitochondria produce hydrogen 
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peroxide (H2O2), which arises from the dismutation of superoxide (O2
-) under the 
influence of superoxide dismutase [26, 102]. In high concentrations, hydrogen peroxide 
has been shown to be the major ROS responsible for damage to equine spermatozoa [80], 
and therefore must be rapidly eliminated from the cell to prevent the induction of 
oxidative damage [101]. Uncontrolled production of ROS that exceeds the antioxidant 
capacity of the seminal plasma leads to oxidative stress and sperm damage [104]. The 
capacity for ROS generation is significantly enhanced in abnormal spermatozoa [80].  
Deficient spermatozoa produce high levels of ROS, which correlates with lower 
motility and decreased sperm functions [104]. Studies have shown that NADPH oxidase 
in the sperm membrane is responsible for the increased ROS generation in defective 
sperm, and activity of sperm diaphorase, which is integrated in the mitochondrial 
respiratory system, is increased in semen of infertile human patients [104].  
The presence of leukocytes in semen has been associated with male infertility as well 
[81]. Polymorphonuclear leukocytes (PMNs) in semen produce different levels of ROS 
depending on their activation level; therefore, activated PMNs could pose a threat to 
spermatozoa [104]. Seminal plasma appears to have sufficient antioxidant or ROS 
scavenging capacity that may help prevent sperm damage by leukocytes [81]. Also, dead 
sperm appears to have a toxic effect on live sperm in the ejaculate, as demonstrated in 
bovine sperm [105].  
ROS may also adversely affect sperm motility via alterations in mitochondrial 
function [80]. Defective spermatozoa often lose their mitochondrial membrane potential 
[26]. Mitochondrial membrane potential has been widely used as a measure of 
mitochondrial function and is linked to ATP synthesis, import of mitochondrial proteins, 
calcium homeostasis, and metabolite transport [80].  
It has been demonstrated in human sperm that spontaneous levels of mitochondrial 
ROS generation are highly correlated with their free polyunsaturated fatty acid content 
[26]. The passive proton permeability of mitochondrial membranes is inversely related to 
their cholesterol content [106]. Therefore, links between diet and oxidative stress in the 
male germ line may exist [26]. 
2.5 Sperm Susceptibility to Lipid Peroxidation (LPO) and LPO Consequences 
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As previously stated, seminal plasma has a highly specialized scavenger system that 
defends the sperm membrane against lipoperoxidation; however, various pathologies and 
systemic predisposition can lead to an antioxidant/pro-oxidant disequilibrium [25], 
leading to oxidative damage of the spermatozoa. Continuing on with the previous 
discussion, it is clear that susceptibility of the sperm plasma membrane to peroxidative 
damage is due to a high cellular content of PUFAs as well as their deficiency in 
protective enzymes [3]. The PUFAs give the sperm plasma membrane the fluidity 
(defined as disorder and rates of molecular reorientation [5]) that the sperm requires to 
participate in membrane fusion events associated with fertilization, such as acrosomal 
exocytosis and sperm-oocyte fusion [25, 89], as well as the structural integrity required 
for viability [80]. However, to reiterate, these molecules are very vulnerable to 
peroxidative attack by reactive oxygen species [3, 25, 26, 89].  
The mechanisms by which lipid peroxidation leads to motility loss in spermatozoa 
likely involves changes in the fluidity and integrity of the plasma membrane and a 
subsequent failure to maintain membrane functions critical to flagellar movement [89]. 
This in turn disrupts other sperm functions which are dependent on membrane activity, 
such as sperm-oocyte fusion and the ability to undergo the acrosome reaction [2]. The 
most significant effect of LPO in all cells appears to be the disruption of membrane 
structure and function, including transport processes, maintenance of ion and metabolite 
gradients, and receptor-mediated signal transduction [81]. However, LPO can also 
damage DNA and proteins, often through oxidation of DNA bases [81].  
Loss of membrane integrity can also lead to an inappropriate increase in membrane 
permeability and a loss in the ability to regulate intracellular concentrations of ions 
responsible for the control of sperm movement [80]. As a consequence of LPO, the 
plasma membrane of the sperm loses PUFAs with the associated production of lipid 
hydroperoxides, alkoxyl and peroxyl radicals [80]. These radicals promote the cascade of 
lipid peroxidation and ultimately lead to the production of cytotoxic aldehydes, such as 
malondialdehyde (MDA) and 4-hydroxynonenol (4HNE) [26, 80]. 4HNE, an aldehyde 
generated as a result of the peroxidative process, causes oxidative modification and 
adduction of functionally important proteins and DNA [26].  
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The process of lipid peroxidation involves the activation of Phospholipase A2 (PLA2) 
to remove the oxidized fatty acid from the parent phospholipid for processing by the 
glutathione peroxidase system, which converts the toxic lipid peroxide into an alcohol, 
which is harmless to the sperm [26]. PLA2 action creates a lysophospholipid, which is 
the compound that ultimately destabilizes the plasma membrane and facilitates a loss of 
membrane integrity [26]. However, once PLA2 has cleaved the peroxidized fatty acid out 
of the membrane, it is taken up by albumin, which is highly effective at protecting 
spermatozoa from oxidative stress [26]. Albumin binds and neutralizes cytotoxic lipid 
hydroperoxides, which is vital because otherwise these hydroperoxides will propagate the 
lipid peroxidation chain reaction throughout the sperm plasma membrane [26]. This 
lipoperoxidative cascade is one of the major factors triggering spermatozoa to begin 
apoptosis [26].  
 
2.6 8-hydroxy-2’-deoxyguanosine (8OHdG) as a Biomarker for Oxidative Stress  
 
Oxidative stress is a major factor contributing to male infertility. It is a major cause of 
DNA damage in mammalian spermatozoa and generates oxidized base products such as 
8-hydroxy-2’-deoxyguanosine (8OHdG) [85]. The level of 8OHdG in DNA from tissues 
or cells can be measured to record the balance between damage and repair [107]. 8OHdG 
and its corresponding base, 8-hydroxyguanine, are useful markers of DNA damage 
because they represent about 5% of the total oxidized bases that are known to occur in 
DNA, and they can be measured with high sensitivity using electrochemical detection 
[108].  
ROS generated during apoptosis can readily gain access to the sperm nucleus and 
generate  
oxidative base adducts, namely 8OHdG [26]. DNA fragmentation in the sperm nucleus, 
which can be measured using a terminal deoxynucleotidyl transferase-mediated dUTP 
nick end labeling (TUNEL) assay, is highly correlated with the formation of 8OHdG 
[26]. This correlation is so significant that it has been concluded that oxidative stress is 
the major cause of DNA fragmentation in human spermatozoa, and likely all mammalian 
sperm [26]. This assumption can be made based on the fact that the only product of the 
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apoptotic cascade that can move from the mitochondria and cytoplasm in the sperm 
midpiece, where apoptosis is initiated, to the sperm head and initiate DNA fragmentation 
would be a membrane-permeant ROS such as H2O2 [26]. 
8OHdG is a biomarker for oxidative stress that is formed during ROS damage to 
DNA, and it is a specific indicator of oxidative stress. 8OHdG formation is correlated 
with impaired mitochondrial membrane potential, superoxide generation and impaired 
chromatin remodeling. Poor quality, low-density sperm, or defective sperm, have 
naturally more 8OHdG generation than healthy sperm. 8-hydroxylation of the guanine 
base is one of the most abundant oxidative lesions possible in DNA [109], and it has 
become increasingly popular as a sensitive, stable, and integral marker of oxidative DNA 
damage [109].  
 
2.7 Ferrous Promoters 
 
Many transition metal ions can participate in the generation of reactive oxygen 
species, as they can change their redox status to either gain or lose an electron [89]. For 
example, in the Fenton reaction, H2O2 undergoes decomposition in the presence of 
ferrous ions to produce OH-  [89], which is extremely damaging to spermatozoa. 
Although other transition metals do react in similar ways, iron is considered the major 
component in these reactions [110]. Both iron and copper are available in a free state in 
seminal plasma, and thus can take part in OH- production and the accompanying 
promotion of oxidative stress [111].  
Lipid peroxidation can be increased in equine spermatozoa stressed with ferrous 
promoters, such as FeSO4 [112]. Even a small amount of Fe(II) in the culture medium 
can trigger a severe lipid peroxidation cascade, leading to a loss of sperm motility and 
other membrane-dependent functions [26]. Production of malondialdehyde (MDA) is an 
end product of LPO induced by ferrous ion promoters [113]. Sperm cells can be 
deliberately stressed with ferrous sulfate and ascorbic acid (FeAA: FeSO4 + ascorbic 
acid), which in bull spermatozoa has been shown to decrease motility and viability, and 
increase lipid peroxidation [114]. The combination of Fe2
+ and ascorbate has been used to 
induce oxidative stress/LPO via hydroxyl radical (OH) formation [114].  
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In human sperm, oxidative stress and DNA damage can be created by incubating 
sperm samples with Fenton reagents consisting of hydrogen peroxide (H2O2) and Fe
2+ in 
a molar ration of 2 : 1 [115]. In the presence of ferric ions, the free radicals superoxide 
and hydrogen peroxide further generate the hydroxyl radical, which is highly detrimental 
to spermatozoa [81].  
 
2.8 Antioxidants and Sperm   
 
Antioxidants are present in the seminal plasma and the sperm cell itself, and help to 
protect the spermatozoa against oxidative stress [116, 117]. The testes also contain many 
antioxidant enzymes and free radical scavengers, which help ensure that spermatogenic 
and steroidogenic functions are not severely impacted by oxidative stress [101]. As 
peroxidative damage is believed to be the primary cause of impaired testicular function, 
these antioxidant defense systems are vital [101]. Antioxidant systems have importance 
in the maintenance of sperm motility, the rate of hyperactivation, and the ability to 
undergo the acrosome reaction during sperm preparation techniques, especially in the 
absence of seminal plasma [81].  
Oxidative stress can cause disruption of the steroidogenic capacity of Leydig cells 
and the ability of the germinal epithelium to differentiate normal spermatozoa [118, 119]. 
Therefore, there is a relationship between oxidative stress in the testes and the 
impairment of male reproductive function, and the complexity of the many potential 
detrimental factors emphasizes the need for an antioxidant supplement to support male 
reproductive health [101]. The discovery of an antioxidant supplement that could help 
increase sperm motility and functionality, as well as decrease the damage caused by 
oxidative stress would be a significant asset to improving male fertility.  
A study done in 2011 by Contri et al. showed that dietary supplementation with the 
antioxidants selenium, vitamin E, and zinc resulted in a significant increase in sperm 
average path velocity, straightness, viability, and total seminal plasma antioxidant levels, 
as well as a significant improvement in progressive motility and a decrease in abnormal 
sperm morphology in antioxidant-treated stallions versus controls [120]. However, the 
positive correlation between progressive motility and total antioxidants in seminal plasma 
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was seen in both treated and control groups [120]. This study concluded that dietary 
antioxidant supplementation could decrease the susceptibility of spermatozoa to ROS-
induced damage or could increase the ability of seminal plasma to reduce the oxidative 
stress [120].  
The selenium content of equine spermatozoa has been found to be positively 
correlated with progressive motility and fertility rate, demonstrating the importance of 
this metal in the regulation of glutathione peroxidase activity [12]. Furthermore, in rat 
sperm, a selenium-associated polypeptide, presumably GSH peroxidase, has been 
demonstrated in the sperm mitochondria to play a role in peroxyl scavenging and in 
maintaining sperm motility [121].  
In boar sperm, improved motility and mitochondrial membrane potential were 
demonstrated as a result of supplementation of semen with the vitamin E analogue Trolox 
[122]. Vitamin E (α-tocopherol), a chain-breaking antioxidant, can terminate lipid 
peroxidation chain reactions [89]. This is very effective in human spermatozoa especially 
[42], and has been demonstrated to improve the fertility of males with high levels of lipid 
peroxidation in their sperm [123]. Another study has concluded that ascorbic acid has 
protective effects on sperm membrane integrity in stallion semen [124]. In cryopreserved 
bovine sperm, the antioxidants α-tocopherol and ascorbate have been shown to have a 
protective effect on both metabolic activity and cellular viability [125, 126].  
Results from Lenci et al. have also indicated that glutathione protects sperm motility 
in vitro, during pelleting, and when there is contact between seminal ROS and normal 
spermatozoa [25]. Human patients receiving glutathione therapy in this study had an 
improvement in sperm concentration, motility, morphology, and kinetic variables [25]. 
These improvements were associated with a decrease in the concentrations of 
lipoperoxides in the spermatozoa and with an increase of the red blood cell 
concentrations of PUFA of phospholipids [25]. Further results from this study 
demonstrated that the arachidonic acid/linoleic acid ratio, which is an indicator of PUFA 
metabolism, in phospholipids of red blood cells and spermatozoa was lower in the 
infertile patients than in fertile patients before commencement of the study. However, by 
the end of the study, concentrations of both linoleic acid and arachidonic acid had 
increased significantly in the red blood cells and serum of treated infertile patients [25]. 
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However, their values still remained lower than those of fertile patients [25]. This 
suggests that the therapeutic action of glutathione is due to its general protective effect on 
the lipid components of the cell membrane [25].  
Glutathione could potentially act by modifying the biochemical constitution of the 
lipid membrane [25], which would confirm experimental data on rats fed a diet deficient 
in essential fatty acids that showed a deficiency of PUFA in serum and semen [35]. GSH 
peroxidase and GSH reductase may also act as antioxidants involved directly in the 
inhibition of sperm lipid peroxidation [81]. GSH likely has a role in sperm nucleus 
decondensation and may alter spindle microtubule formation in the ova, thus affecting 
pregnancy outcomes [81].  
Interestingly, one of the most effective antioxidants that has been proven to 
effectively protect testicular function is melatonin [101]. In stallion sperm, melatonin 
reduces lipid peroxidation and apoptotic-like changes [127]. Melatonin has been shown 
to decrease oxidative stress in the testes induced by multiple different stress-causing 
agents, including ethanol [128] and streptozotocin-induced diabetes in rats [129].  
However, an additional study in pony stallions that supplemented tocopherol, 
ascorbic acid, L-carnitine, and folic acid, declared that this dietary antioxidant 
supplementation may not result in pronounced effects on semen quality of stallions [130]. 
Similarly, Ball has demonstrated that the addition of antioxidants to skim milk-based 
extenders did not improve the maintenance of motility during cooled storage of equine 
sperm [131, 132].  
ROS generation, and the lipid peroxidation pathways they induce, should be 
counteracted by the inclusion of nucleophiles to remove cytotoxic aldehydes and 
antioxidant free radical scavengers [26]. Nucleophiles are chemical species that donate 
electron pairs to electrophiles to form a chemical bond. Any molecule or ion with a free 
pair of electrons can act as a nucleophile. Studies have demonstrated that the increase in 
mitochondrial free radical production correlates with a loss of protein thiols as well as a 
rise in the formation of 4-hydroxynonenal, which is an electrophilic product of lipid 
peroxidation that suppresses sperm movement [133]. Since nucleophiles form covalent 
bonds with nucleophiles, a search was conducted for nucleophiles that could counteract 
the negative effects of these electrophilic compounds. It was discovered in three species 
24 
 
(human, rat, and horse) that penicillamine, homocysteine, N-acetylcysteine, and 
mercaptosuccinate, all nucleophilic compounds, could support proper sperm function 
[133]. The prosurvival effects supported by these nucleophiles stabilized 4-
hydroxynonenol generation, helped preserve sperm thiols, and reduced 8OHdG formation 
[133].  If these counteractive measures should prove effective in future studies as well, 
equine spermatozoa may be able to be better preserved at ambient temperatures, and the 
irreparable damage induced by cooling and freezing sperm may be avoided [26].  
The antioxidant defenses of whole semen decrease significantly upon 
cryopreservation due to multiple reasons, including the removal of antioxidant-containing 
seminal plasma from the ejaculate as well as the disruption of antioxidant detoxification 
mechanisms due to an excess of ROS [1]. Supplementation of the antioxidants 
methionine, carntitine, and inositol by direct addition to semen prior to cryopreservation 
has been shown to protect DNA integrity against cryodamage in bovine sperm [134]. All 
of the antioxidants supplemented to semen at both 2.5 and 7.5 mM concentrations 
resulted in lower damaged sperm numbers than that of control semen, though there was 
not a significant increase seen in motility or sperm motion characteristics between groups 
[134].  
Ultimately, the need for further investigation into both dietary and direct antioxidant 
supplementation to semen and extender is needed to establish whether or not there is a 
significant positive effect on stallion semen characteristics.  
 
2.9 Semen Cryopreservation and Cooling 
 
Artificial insemination (AI) is an increasingly popular and important tool in the 
advancement of the agricultural industry’s animal production [1]. Therefore, successful 
semen cryopreservation is a necessity in order to enhance the advantages of AI [1]. 
Cryopreserved semen is able to be stored long-term and thus can be transported long 
distances and used for an extended period of time, which is especially useful after the 
death of a genetically superior sire [1].  
However, cryopreservation appears to cause irreversible damage to spermatozoa, 
plummeting down to a 20-50% decrease in fertilization ability than that of fresh semen in 
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different species [135, 136]. This decrease in fertility is due to the fact that 
cryopreservation causes both a loss of sperm viability as well as an impairment of 
function in the population that does survive [137].  
Sperm cryoinjury causes severely impaired transport and poor survival in the female 
reproductive tract [138], and in sheep, laparoscopy is commonly used to perform direct 
oviductal insemination instead of traditional vaginal or transcervical insemination [1]. 
When the spermatozoa are placed higher in the female reproductive tract than is normally 
the case with artificial insemination, fewer sperm are required to achieve the same 
probability of fertility [137]. Maxwell demonstrated in 1986 that only 20 million motile 
cryopreserved ram sperm were required to achieve greater than 50% fertility when a ewe 
was inseminated intrauterine, whereas cervical insemination of cryopreserved ram sperm 
required 10 times that dose [139]. Even less spermatozoa was needed if the insemination 
was made into the oviduct itself—Less than one million spermatozoa [136]. These 
observations are presumably because cryopreserved spermatozoa do not survive in the 
female reproductive tract compared with fresh sperm [137]. 
As spermatozoa are quite susceptible to cold shock, it is necessary to improve 
cryopreservation techniques to decrease sperm damage during the processes of freezing 
and thawing, which generate significant amounts of ROS. The sperm plasma membrane 
is the primary structure detrimentally affected by cryopreservation [140-142], as it is the 
main physical barrier to the outside environment [143]. Thus, the freeze/thaw process 
results in an increase of the LPO cascade, ROS generation, and decreased antioxidant 
levels [144], which ultimately result in a decreased ability for the sperm to bind and react 
with the zona pellucida [145]. Dobrinski et al. (1995) demonstrated that cryopreserved 
stallion sperm were less able to bind to zona pellucidae than sperm stored at room 
temperature [146]. Also, even if frozen-thawed spermatozoa successfully bind to the zona 
and cause fertilization, they are then associated with an increased incidence of early 
embryonic mortality [138].  
Semen cryopreservation exerts such significant stresses on sperm cells that it can 
severely decrease motility, viability, and the ability of the sperm to fertilize an oocyte. 
Cryopreservation induces the formation of intracellular ice crystals, sperm damage 
caused by osmotic and chilling stress, cytoplasm fracture, and effects on the cytoskeleton 
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[147]. Significant and irreparable membrane permeabilization results after sperm are 
exposed to a high salt concentration even if osmotic equilibrium is then restored, and this 
indeed occurs during the freeze-thaw process [1].  
Phospholipids, especially those in egg yolk, protect sperm to some extent from cold 
shock and also prevent increased calcium flux into the sperm, hence the reason for the 
common use of an egg yolk-based extender when cryopreserving semen [43]. Egg 
phosphatidylcholine, a fluid lipid containing highly mobile acyl chains, has been shown 
to decrease sperm lipid transition temperature and in turn decrease sensitivity to freezing, 
while on the other hand a more rigid lipid, dipalmitoyl phosphatidylcholine, had the 
opposite effect [143]. This suggests that the effects of different lipids on the sperm 
plasma membrane during the phase changes resulting from cryopreservation is correlated 
with their fluidity [143].  
However, studies have shown that pure lipid-based extenders can prevent membrane 
damage to the sperm cell during cryopreservation just as well as a standard egg-yolk 
extender, and can help preserve sperm viability, motility, and fertility [143]. There are 
multiple hypotheses as to the mechanism of cryoprotection by exogenously added lipids, 
including first that exogenous lipids can associate with the sperm plasma membrane, and 
second that they can potentially modify membrane composition [148]. In a study by 
Ricker et al. (2005), lipid-treated sperm that were frozen and thawed showed the 
presence of lipid aggregates on the membrane surface that were absent in untreated 
samples undergoing the same procedure, demonstrating that even after post-thaw 
washing, exogenous lipid remains associated with the sperm membrane [143]. Lipid-
treated sperm were also morphologically intact, with smooth, unmarred membrane 
surfaces [143]. The results from this experiment demonstrate that although exogenous 
lipid from cryoprotective agents does not actually incorporate into the sperm membrane, 
it does strongly associate with the membrane surface, thus providing a physical barrier to 
freeze-thaw damage and helping to prevent membrane phase separation [143]. 
Another experiment utilizing the addition of cholesterol and cholestanol-loaded 
cyclodextrins in stallion sperm was done by Moraes et al. (2015), where it was proven 
that higher percentages of motile and viable spermatozoa were achieved with this 
treatment after cryopreservation and thawing processes [149]. The added cholesterol and 
27 
 
cholestanol-loaded cyclodextrins were incubated for 15 minutes at 22 °C and allowed to 
incorporate into the sperm membrane. This study also demonstrated that addition of 
cyclodextrin pre-loaded with cholestanol resulted in an increased number of sperm 
binding to the perivitelline membrane of chicken eggs [149]. The conclusion of Moraes’ 
study proved that the addition of both cholesterol and cholestanol-loaded cyclodextrins 
improved the post-thaw motility of equine sperm, and that cholestanol-loaded 
cyclodextrin also improved binding efficiency [149]. Similar studies have been done in 
bull, boar, and ram sperm, where it was proven that the addition of cholesterol-loaded 
cyclodextrins to the sperm increases its cryosurvival [150-152]. However, Oliveira et al. 
(2014) has shown that although the use of cholesterol-loaded cyclodextrin in donkey 
semen did improve sperm viability, it also resulted in lower fertility in mares [153]. Thus, 
further studies are needed in order to delve deeper into this matter.  
The sperm cell membrane undergoes many damaging changes during the 
cryopreservation process—Temperature changes alter the physical properties of the 
membrane, and a large volume change occurs due to freezing of the cell [142]. Lipid 
phase transitions cause the clustering of integral membrane proteins, which can 
presumably alter their function [137]. Proteins which undergo structural modulations in 
order to carry out their functions, such as ion channel proteins, may be especially 
susceptible to this clustering [137]. 
 Phase transitions that occur upon cooling detrimentally alter sperm membrane 
structure in a manner that is not reversible upon thawing [1]. In ram, boar, and stallion 
sperm, cryopreservation affects lipid composition and organization of sperm plasma 
membranes [1]. Freezing causes lipid phase separation of the plasma membrane of the 
sperm cell, which results in irreversible damage to the cell [143]. Ricker et al. conducted 
a study in 2005, in which they compared fresh sperm to post-thaw sperm and found that 
post-thaw spermatozoa showed significant lipid phase separation and rearrangement 
[143]. These lipid phase transitions caused by cold shock damage result in the sperm 
membrane becoming leaky, which compromises membrane integrity [154, 155]. The 
resulting structural damage to membranes due to the effects of cryopreservation 
procedures destabilizes them, which predisposes sperm to morphologic defects such as 
abnormal acrosomes [1].  
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The susceptibility of the sperm plasma membrane to damage by cryopreservation has 
been shown to be inversely related to the proportion of cholesterol present in the 
membrane [148, 154]. For example, lower cholesterol levels are present in bull and ram 
sperm, which are sensitive to cooling, as compared to rabbit and human sperm, which are 
less susceptible to cooling damage [1].  Few studies have been conducted on the lipid 
composition of stallion sperm membranes, although it has been shown that cholesterol is 
the primary sterol present in the membrane. It can however be inferred that the 
cholesterol content of stallion sperm may be lower than that of rabbit and human sperm, 
for example, since stallion sperm is much more susceptible to cold shock than these 
particular species. Also, sperm with higher ratios of unsaturated to saturated fatty acids in 
the membrane, such as that of the bull, ram, boar, and stallion, are more sensitive to cold 
shock than sperm with lower ratios, such as rabbits, dogs, and humans [1]. Due to this 
fact, it would seem that the supplementation of a polyunsaturated fatty acid such as DHA 
to spermatozoa could be contraindicative. However, the extent to which DHA 
significantly improves membrane fluidity and flexibility causes it to be a beneficial 
addition to the sperm plasma membrane.  
Cold shock due to the freezing process also ruins the selective permeability of the 
sperm membranes to calcium, thus leading to excessive intracellular calcium levels, 
which ultimately reduce motility and cause necrosis [146, 156]. The restructure of sperm 
plasma membranes and altered lipid-protein associations that occur during 
cryopreservation are assumed to favor this inappropriate calcium influx [1]. The elevated 
levels of intracellular calcium in cryopreserved sperm may also explain the poorer 
fertility of frozen/thawed spermatozoa in bovine and human sperm [157-159], though 
bovine sperm still freezes better than equine sperm. Normally, during capacitation [160], 
hyperactivation [161], and the acrosome reaction, calcium levels in sperm increase [162, 
163]. Elevated sperm calcium levels are thought to trigger an intracellular signaling 
cascade that is associated with capacitation [1]. Disrupting capacitation or the acrosome 
reaction, as occurs during cryopreservation procedures, compromises the fertilizing 
potential of spermatozoa [158].  
Because of the temperature and osmotic effects, both freezing and thawing semen 
induce significant alterations in cell water volume, which confers a large amount of 
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mechanical stress on the sperm plasma membrane [1]. Stresses induced by ice crystal 
formation during the sperm cryopreservation process are mainly associated with 
accompanying osmotic pressure changes [164]. The proportion of water crystalizing out 
as ice and the remaining liquid water fraction determines the osmotic strength of the 
remaining solution, and as the solutes dissolve in the remaining liquid water, the osmotic 
strength rises [137]. Therefore, it would be ideal to uncover the maximal cooling rate 
compatible with osmotic equilibrium in order to optimize cryopreservation techniques 
[137]. The cooling rate must be slow enough to allow water to leave the cells by 
osmosis—This will prevent intracellular ice crystal formation, which is lethal to 
spermatozoa [137].   
Increases in osmolarity associated with cryopreservation of spermatozoa stimulate a 
ROS-dependent increase in tyrosine phosphorylation that may account for the premature 
capacitation-like effects seen in frozen/thawed stallion sperm [165]. It has been shown 
that cryopreserved sperm are in a partially capacitated state [141], proven by their ability 
in certain species, such as bovine, to fertilize homologous oocytes in vitro without any 
pretreatment normally required by uncooled sperm [166, 167].  
Sperm capacitation has been appropriately described as a “window of destabilization” 
through which sperm acquire fertilizing capabilities but are also very susceptible to 
membrane degeneration and spontaneous acrosome reactions if they do not fertilize an 
oocyte [168]. Capacitation includes reorganization of the sperm head plasma membranes 
due to both phospholipid redistribution and cholesterol removal [169, 170]. This proves 
that both cooling and cryopreservation processes alter both the architecture of sperm 
membrane’s and their behavior [1]. Cryo-capacitation appears to be partly, though not 
entirely, induced by ROS activity generated during the sperm freeze/thaw process [1], a 
hypothesis that is supported by the fact that in vitro capacitation and tyrosine 
phosphorylation of sperm proteins are correlated with superoxide anion generation in 
human sperm [171].   
There are also osmotic stresses implored on cryopreserved spermatozoa upon 
rewarming [172]. The proportion of sperm cells that survive the freezing and thawing 
processes is determined by the sensitivity to osmotic stress during the addition and 
removal of cryoprotectants [137]. Since the ejaculate is heterogenous, different 
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spermatozoa have varying tolerances to osmotic stress—Some will succumb to lethal 
damage, whereas others will survive and retain the capacity for fertilization [137]. 
Studies have shown that certain particular individuals can possess spermatozoa that are, 
in general, more tolerant than the spermatozoa of other individuals, suggesting that 
certain characteristics of membrane structure predispose towards survival during 
cryopreservation [137]. 
The ultimate goal of cryopreservation research is to develop optimal cryopreservation 
conditions for spermatozoa of multiple different species. In order to achieve this goal, 
possible research approaches could include improving membrane stability during 
cryopreservation to help prevent the elevation of sperm calcium levels, as well as 
improved efforts to control ROS production during sample processing [1].  
 
2.10 Flow Cytometric Evaluation of Spermatozoa   
 
Semen samples are commonly analyzed in the laboratory prior to artificial 
insemination. This analysis generally includes an evaluation of the percentage of motile 
sperm (often with the use of a Computer Assisted Sperm Analysis (CASA) machine), the 
percentage of sperm with normal morphology, and the concentration of the sperm in a 
breeding dose [173]. The main objective of these analyses is to quickly and accurately 
predict the possible fertilization capability of a given semen sample. Unfortunately, these 
laboratory assays have not correlated well with the fertilizing capacity of the spermatozoa 
[173], proving that new methods of analysis are needed. 
Flow cytometry allows for the evaluation of physical characteristics, such as cell size, 
shape, and internal complexity, as well as any component or function of the 
spermatozoon that can be detected by a specific fluorochrome or fluorescently labeled 
compound [173]. Flow cytometry is also able to detect labeling by multiple 
fluorochromes together, each associated with different individual spermatozoa, meaning 
that more than one attribute of the sperm can be measured simultaneously [173]. A flow 
cytometric analysis also measures, in general, 10,000 spermatozoa, in contrast to the 200 
or so evaluated with a microscopic evaluation [173]. This gives flow cytometry a further 
advantage to traditional semen evaluation practices. The relatively recent discovery of 
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different fluorochromes and compounds conjugated to fluorescent probes has enabled a 
more widespread analysis of sperm attributes [173].  
Different staining techniques help to evaluate different properties of spermatozoa on 
the flow cytometer, for example, the DNA status of spermatozoa has been determined 
using acridine orange (AO) [173]. AO staining has been shown to correlate with fertility 
in many different species [173]. Using AO, one can evaluate sperm chromatin structure, 
as AO binds to denatured, single-stranded DNA as aggregates in damaged sperm and 
emits red fluorescence when the DNA-associated protamines are poor in disulfides [174]. 
However, when DNA-associated protamines are rich in disulfides, such as is the case in 
healthy sperm, AO fluoresces green when it binds to native, double-stranded DNA as a 
monomer [174]. This transformation of sperm nuclei from fluorescing red to fluorescing 
green demonstrates the cross-linking of nuclear protamines, which is a normal process of 
sperm maturation [174]. Since the integrity of the nucleus is clearly vital for the viability 
of spermatozoa, in some cases its assessment with the use of AO may be useful in 
diagnosing fertility problems.  
Using the terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling 
(TUNEL) assay, DNA fragmentation can be assessed. The TUNEL assay identifies DNA 
strand breaks, present in functionally impaired sperm [115], by labeling free 3’-OH 
termini with modified nucleotides [173], and the output of the TUNEL assay has been 
shown to be highly correlated with sperm vitality [115]. The TUNEL assay depends upon 
the ability of the protein terminal transferase to access DNA strand breaks and catalyze 
the insertion of labeled bases, however this task is difficult to achieve in the highly 
compacted chromatin structure of the sperm membrane [115]. Protamine disulfide bonds 
are created to reinforce the compactness and stability of the chromatin during epididymal 
transit of the spermatozoa [115]. Therefore, it is necessary to find a way to relax the 
chromatin structure of spermatozoa to allow the terminal transferase proteins access to 
DNA strand breaks in the sperm nucleus [115]. Dithiothreitol (DTT) is a mass reducing 
agent that has been shown to effectively relax chromatin structure by breaking the 
disulfide bonds between adjacent protamine molecules [115].  
LysoTracker Green DND-26, a fluorescent acidotropic probe, can help determine the 
status of the sperm acrosome, while chlortetracycline (CTC) and Merocyanine 540 allow 
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the observation of capacitation status [173]. Cell viability can be determined using 
propidium iodide (PI), ethidium homodimer-1 (EthD-1), or Yo-Pro-1 to permeate 
damaged membranes [173]. Non-viable cells are determined using these membrane-
impermeable nucleic acid stains, which positively identify dead spermatozoa by 
penetrating their damaged membranes [173]. Viable sperm cells with intact membranes 
do not allow for penetration by these stains, therefore only the non-viable sperm cells will 
be fluorescently labeled.  
Using MitoTracker Green FM (MITO) and 5,5’,6,6’-tetrachloro-1,1’,3,3’-
tetraethylbenzimidazolyl-carbocyanice iodide (JC-1), one can determine mitochondrial 
function [173]. All functioning mitochondria stain green with MITO, so no distinction 
can be made between spermatozoa exhibiting different respiratory rates [173]. JC-1, 
however, does allow for a distinction to be made between spermatozoa with poorly and 
highly functioning mitochondria [173]. JC-1 is internalized by all functioning 
mitochondria, where it fluoresces green, however in very highly functioning 
mitochondria the concentration of JC-1 inside the mitochondria increases and the stain 
then forms aggregates that fluoresce orange [19, 173].  
SYBR-14 is a membrane-permeant DNA fluorochrome, which labels viable cells 
with functional ion pumps [173]. Currently one of the most popular viability stain 
combinations is SYBR-14 and PI, commercially sold as LIVE/DEAD Sperm Viability 
Kit (Molecular Probes Inc., OR, USA) [66]. When used in combination, the nuclei of 
living sperm fluoresce green (SYBR-14) and non-viable, dead spermatozoa fluoresce red 
(PI) [173].  
Clearly, flow cytometric methods can be used to evaluate many different aspects of 
spermatozoa. The flow cytometer can be used to evaluate semen for traits such as cell 
viability, acrosomal integrity, mitochondrial function, capacitation status, membrane 
fluidity, and DNA status [173]. 
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Chapter Three: Effects of Feeding a Yeast-Based Supplement Containing DHA From a 
Heterotrophically Grown Microalgae, Vitamin E, and Selenium on Stallion Sperm 
Motion Characteristics 
 
3.1 Introduction 
 
Equine breeding is a multi-billion dollar industry encompassing many different 
breeds and disciplines. The majority of livestock breeding industries utilize artificial 
insemination (AI) for impregnating females, due to its efficiency and effectiveness [1]. 
Most major equine breed registries in the United States currently allow the use of AI with 
fresh, cooled, and frozen semen. Unfortunately, the viability and fertilization capability 
of equine spermatozoa decreases with cooling and freezing. This decrease is due in part 
to the lipid peroxidation cascade and generation of reactive oxygen species (ROS) [2], 
which cause oxidative stress. Oxidative stress appears to be the main pro-death stimulus 
regulating the lifespan of spermatozoa [3], and it is important to understand the 
mechanisms behind sperm cell damage and demise in order to be able to improve current 
cryopreservation protocols.  
Enhancing the fertility of cooled and cryopreserved spermatozoa would improve 
pregnancy rates after the freezing and thawing process. A product that could alter 
spermatozoa so that they are better able to withstand the stresses of cooling and freezing 
would be a valuble addition to equine breeding practices. Unfortunately, out of many of 
the products tested to potentially remove the irreversible damage that is induced by 
cryopreservation, only a few have been promising. The major fatty acid in the stallion 
sperm plasma membrane is docosahexaenoic acid (DHA) [4], (C22:6 n-3), an omega-3 
polyunsaturated fatty acid (PUFA) with 22 carbons and 6 double bonds. It is the longest 
chain and most unsaturated fatty acid found commonly in biological systems, making it 
possibly the most influential of the omega-3 group of polyunsaturated fatty acids [5, 6]. 
Studies have shown that feeding fish oil that is high in DHA content improves sperm 
motility, viability, and acrosomal integrity in men [7], bulls [8, 9], boars [10], and rats 
[11].  
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The number of studies in stallions on the use of omega-3 fatty acids has been 
limited. Brinsko et al., fed a supplement high in DHA to stallions for 14 weeks and found 
increased motility and the percentage of rapidly motile sperm after 48 hours of cooling 
and storage at 5 °C [12]. Post-thaw sperm motility of frozen semen tended to increase for 
those stallions that were supplemented with DHA [12]. In a similar study (Squires, 
unpublished), stallions fed 15g of DHA had increased sperm motility in fresh semen as 
well as in sperm that were cooled for 24 hours at 5 °C. The Brinsko study demonstrated 
that DHA was in fact incorporated into the sperm membrane, and thus theoretically could 
be used to alter the stallion sperm to better withstand the stresses of cooling and freezing.  
Therefore, more studies in regards to the use of omega-3 fatty acids in stallions 
are needed to optimize the potential beneficial effects of these fatty acids. Many of the 
products currently on the market with supposed benefits to semen parameters in stallions 
do not contain sufficient levels of the appropriate omega-3 fatty acids or antioxidants, and 
are generally not very palatable. Because sperm damage is believed to be related to 
reactive oxygen species, including antioxidants which help protect spermatozoa against 
oxidative stress along with DHA in a supplement may improve response to a particular 
product. Thus, there is the need for a product that is both palatable and contains high 
levels of DHA and antioxidants.  
The objectives of our initial study were to determine if a DHA-rich microalgae 
meal with selenium and vitamin E would enhance the motility of stallion sperm in fresh, 
24- and 48-hour cooled, and frozen semen. We then analyzed additional frozen semen 
with the intention of viewing differences between control and DHA-treated 
frozen/thawed sperm samples in their ability to withstand oxidative stress.  
 
3.2 Materials and Methods 
Animals 
 
All animal experimentation was conducted according to a protocol approved by 
the Institutional Animal Care and Use Committee at the University of Kentucky. Twelve 
breeding stallions housed at the University of Kentucky research farm, aged 3-12 years 
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old, were used in this study. Prior to the study, management of the stallions included 
housing each stallion in a large individual paddock, with twice a day feedings of 0.4% 
BW as concentrate and grass hay ad libitum. Upon initiation of the study, semen was 
collected every other day for two weeks starting in July 2014, and sperm motion 
parameters (total and progressive motility) were determined by computer assisted sperm 
analysis (CASA, MOFA SpermVision, Verona, WI, USA).  
The last three ejaculates from each stallion were cooled to 5 °C (Equitainer, 
Hamilton Thorne, Beverly, MA, USA) and held for 48 hours and then evaluated. 
Stallions were then paired based on CASA values for motility parameters for both fresh 
and cooled semen, age of stallion, sperm output, and body condition score, and randomly 
assigned to control or treated groups. 
Stallions were fed one of two dietary treatments for 60 days (first day of treatment 
= day 0): Control, a basal diet of 0.4% BW as concentrate (50/50 mixture of whole oats 
and pellets (12% protein, 5.5% fat, 15% fiber, 0.70% calcium, 0.25% phosphorus)) and 
grass hay ad libitum, and DHA-treated, the same basal diet plus 160 g of a yeast-based 
supplement containing 15g DHA from a heterotrophically grown microalgae, 1000 IU 
vitamin E and 2mg selenium as selenized yeast (Alltech Inc., Nicholasville, KY, USA). 
All stallions accepted consumption of the supplement within a few days of feeding. 
 
3.3 Experimental Design 
 
Beginning on day 46 of the treatment period, stallions had semen collected every 
other day until day 60. Sperm motion parameters were assessed using CASA.  
 
Semen Collection, Processing, and Evaluation 
Semen was collected from stallions using a Missouri model artificial vagina, 
lubricated and pre-warmed to 45-50°C, with an inline filter for separation of the gel 
fraction. Volume of gel-free semen was recorded using a digital scale, and concentration 
determined using a 591B Densimeter (Animal Reproduction Systems, Chino, CA, USA). 
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Total sperm numbers were calculated and both total and progressive motility analyzed 
using CASA. For use on CASA, eight microliters of extended sperm suspension were 
placed on a microscope slide (22x22-2 mm coverslip) at 37°C and allowed to stabilize for 
30 seconds prior to acquiring the data. The settings of CASA were as follows: Level 1 
cell classifications: Immotile = AOC (average orientation change of the head) <7; locally 
motile = DSL (distance straight line) <6. Level 2 classifications: Hyperactive= VCL 
(velocity curved line) >8, LIN (linearity) <0.65, and ALH (amplitude lateral head 
displacement) >6.5; linear= STR (straightness) >0.9 and LIN>0.5; non-linear= STR<0.9 
and LIN<0.5; curvilinear= DAP (distance average path)/radius ≥3 and LIN<0.5. Cell 
identification was set for an area of 14 to 80μm2. Motility assessment was repeated with a 
minimum of 7 fields or 500 cells. Following this initial evaluation, the ejaculate was 
prepared for cooling and freezing as follows. 
 For cooling, raw semen was extended using EZ-Mixin CST skim milk-based 
extender (Animal Reproduction Systems, Chino, CA, USA) to 30 x 106 progressively 
motile sperm/mL. Extended semen was placed into two 2 mL Eppendorf tubes, one 
sample tube for evaluation at 24 hours of cooling and another for evaluation at 48 hours 
of cooling. Samples were placed in the Equitainer along with two cans of frozen water-
based solution and stored for their appropriate amount of time. When samples were ready 
for evaluation, they were warmed in a 37 °C incubator for 10 minutes and evaluated for 
total and progressive motility via CASA.  
 For freezing, raw semen was extended at 1:1 using the same EZ-Mixin CST skim 
milk-based extender pre-warmed at 37 °C.  Extended semen was poured into 50 mL 
conical tubes up to 40mL, leaving enough space for both air and cushion fluid.  
Approximately 3 mL cushion fluid (SemSep Equine Cushion Fluid, MOFA, Verona, WI, 
USA) was added to the bottom of the tube, with a sharp interface achieved by slowly 
passing the cushion fluid through the extended semen using a syringe and sterile spinal 
needle. Samples were centrifuged for 25 minutes at 1000 x g. and the supernatant 
containing seminal plasma and debris was then aspirated without disturbing the sperm-
rich layer of the sample or the cushion. Approximately 3 mL of sperm rich layer 
remained on top of the cushion post-aspiration. Cushion fluid (approximately 3 mL) was 
then removed by piercing through the middle of the sperm rich layer using a syringe and 
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spinal needle, leaving ~3mL of remaining sperm-rich pellet in the conical tube. Assuming 
a 50% recovery of sperm, EZ-Freezin LE egg yolk-based extender (Animal Reproduction 
Systems, Chino, CA, USA) was then added to the sperm-rich pellet for a final 
concentration of 200 x 106 progressively motile sperm/mL. A hemacytometer count was 
used to determine total cells recovered and to determine the sperm concentration in the 
tube of the sperm pellet plus extender and the final concentration adjusted to 200 x106. 
Extended semen was loaded into 0.5 mL straws using a bubbler to create air bubbles in 
each straw in order to prevent bursting of straws during the freezing process. Semen 
straws were then placed on a freezing rack in a programmable freezer pre-cooled to 20°C 
and pre-set to a cooling curve of -0.5°C/min from 20°C to 5°C, -10°C/min for the 5°C to 
-15°C, and finally -25°C/min for -15°C to -120°C.  
Frozen straws were then plunged into a liquid nitrogen bath, loaded into goblets, 
and stored in liquid nitrogen tanks until the time of analysis. At the time of analysis, 
frozen semen straws were transferred to a 37 °C water bath and allowed to thaw for 30 
seconds. Once thawed, samples were evaluated using CASA and total and progressive 
motility recorded.  
 
Frozen Sample Analysis 
 
 Two frozen/thawed semen straws were evaluated for frozen sample analysis. One 
thawed sample from each of the last two days of each time period (pre and treatment) 
were warmed to 37 °C, diluted to 30 x 106 spermatozoa/mL, transferred to an Eppendorf 
tube, and post-thaw total and progressive motility determined at T0 and T30 with CASA. 
T30 samples were held at 37 °C until the time of evaluation. Samples were then stained 
as following for analysis on the Accuri C6 Flow Cytometer (BD Biosciences, Accuri 
Cytometers Inc., Ann Arbor, MI, USA).  
 For examination of mitochondrial membrane potential, 3mM 5,5’,6,6’-
tetrachloro-1,1’,3,3’-tetraethylbenzimidazolyl-carbocyanice iodide  (JC-1) (Thermo 
Fisher Scientific Life Technologies, Grand Island, NY, USA) was added to 1 mL of 
spermatozoa concentrated to 5 x 106 sperm/mL in phosphate buffered saline (PBS). Cells 
were incubated with the JC-1 for 30 minutes at 37°C before analysis on the flow 
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cytometer. To view lipid peroxidation, 2 µM Bodipy 581/591 C11 (Thermo Fisher 
Scientific Life Technologies, Grand Island, NY, USA) was added to 1 mL of 
spermatozoa concentrated to 5 x 106 sperm/mL in PBS, and cells were incubated for 30 
minutes at 37°C prior to flow cytometer analysis. For sperm viability testing, YO-
Pro/Propidium Iodide (PI) (Thermo Fisher Scientific Life Technologies, Grand Island, 
NY, USA) staining was used at a concentration of YO-Pro 25mM to PI 12 µM. Cells 
stained for sperm viability were incubated for 30 minutes at 37°C prior to flow cytometer 
analysis. Acrosomal status was measured using Fluorescien Isothiocyanate Peanut 
Agglutinin/Propidium Iodide (FITC-PNA/PI) (Thermo Fisher Scientific Life 
Technologies, Grand Island, NY, USA) at a concentration of 10 µg/mL FITC-PNA to 25 
µg/mL PI, and cells were incubated as described above. Finally, membrane fluidity was 
evaluated using Merocyanine 540/YO-Pro (Thermo Fisher Scientific Life Technologies, 
Grand Island, NY, USA) at a concentration of 1.4 µM Merocyanine to 50mM YO-Pro, 
cells were incubated as previously described and analyzed on the flow cytometer.  
 
Oxidative Challenge Procedure  
 
Two frozen semen straws from the last two days of the treatment period were 
removed from the liquid nitrogen storage tank and placed in a 37°C water bath for 30 
seconds. Frozen/thawed semen was then diluted in a Biggers, Whitten, and Whittingham 
(BWW) + polyvinyl alcohol (PVA) solution of 1 mg/mL and 100 million sperm 
centrifuged over a colloidal 40% and 80% density gradient (PureSperm 100 and 
PureSperm Buffer, Nidacon, Mölndal, Sweden). After centrifugation at 300 x g for 20 
minutes, sperm pellets were resuspended in either 200 μL prepared oxidative challenge 
solution (2mM H2O2 and 1mM FeCl2-4H2O), or simply 200 μL BWW + PVA solution 
for use as a control sample. Resuspended sperm cells were incubated for 2 hours at room 
temperature, and then washed twice with 200 μL BWW + PVA solution by centrifugation 
at 600 x g for 5 minutes. Washed sperm cells were then resuspended in 100 μL of 2 mM 
dithiothreitol (DTT) prepared stock solution for breakage of disulfide bonds, and were 
incubated for 45 minutes at 37°C. Cells were again centrifuged at 600 x g for 5 minutes 
and the supernatant aspirated. Following centrifugation, the sperm pellet was resuspended 
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in 100 μL of 1x PBS and 100 μL of 4% paraformaldehyde for fixation purposes, and the 
cells incubated at 4°C for 15 minutes. Cells were washed in 200 μL 1x PBS at 600 x g for 
5 minutes, and stored in 200 μL of 0.1 M Glycine at 4°C for a maximum of one week. 
When ready for analysis, fixed cells were washed with 200 μL 1x PBS by centrifugation 
at 600 x g for 5 minutes. Washed cells were then resuspended in 100 μL of 0.2% Triton-
X for permeabilization and incubated at room temperature for 15 minutes. Cells were 
centrifuged at 600 x g for 5 minutes, and then resuspended in 1 mL diluted Wash 
Solution (Calbiochem OxyDNA Assay Kit, Fluorometric, Merck KGaA, Darmstadt, 
Germany). Resuspended cells were then separated into 4, 15 mL conical tubes for control 
stained/unstained, and oxidative challenge treated stained/unstained, and again 
centrifuged at 600 x g for 5 minutes. Pellets to be stained were resuspended in 100 µL of 
1×FITC-Conjugate and incubated for 1 hour at room temperature in the dark. Unstained 
cells were resuspended in 200 μL 1x PBS. After the hour incubation time, all four sperm 
samples were washed in 200 μL 1x PBS at 600 x g for 5 minutes, and finally resuspended 
in 1 mL PBS. 
 Cells were viewed under an Axio Scope.A1 polarized light microscope (Carl 
Zeiss Microscopy LLC, Thornwood, NY, USA) to ensure that there was no clumping and 
individual cells were clearly visible, and then transferred to 1 mL Eppendorf tubes for 
flow cytometric analysis. The formation of 8-hydroxy-2’-deoxyguanosine (8OHdG) was 
measured on the flow cytometer using the antibody conjugated to FITC from the 
OxyDNA Assay kit mentioned above and the intensity of FITC fluorescence measured 
using the FL-1 filter on the flow cytometer.  Increasing intensity of FITC fluorescence 
indicates that the spermatozoa succumbed to a higher level of oxidative damage. 
Analysis of frozen semen used the same methods as above, with the intentions of 
viewing any differences between the cryopreserved semen of stallions treated with the 
DHA/Vitamin E/Selenium supplement versus the cryopreserved semen of control 
stallions. Per stallion, two cryopreserved semen straws were analyzed from the last two 
days of the treatment period.  
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3.4 Statistical Methods 
 
For the initial DHA study, using JMP software (SAS, Cary, NC, USA), a mixed 
model with ejaculate and stallion as random effects was used for statistical analysis of 
fresh, cooled, and frozen semen. The last three ejaculates of the pre- and the treatment 
period were used for statistical analysis of fresh and cooled semen. Time (0, 24, 48 
hours), treatment group (control/treatment), and period (pre/treatment) were used as fixed 
effects. Based on the significant treatment by period interaction, post-hoc analyses were 
done via a Tukey’s High Significance Difference (HSD) test in order to evaluate 
differences between control and treated animals. Least squared means were represented ± 
standard error of the mean and the significance was set at p-value < 0.05. Statistical 
analysis of frozen semen was done using the same method, but using two thawed semen 
straws, and with the time points of 0 and 30 minutes rather than 0, 24, and 48 hours.  
Analysis of poor coolers vs. good coolers was also done with the mixed model 
method as above. Treated stallions were labeled with a cooling score of either 1 (poor 
coolers, <40% PMS), or 2 (good coolers, >40% PMS). A comparison of treated stallion 
sperm from the pre-treatment to treatment periods at both cooled 24 hour and cooled 48 
hour time points was done to evaluate differences of treatment effects in poor coolers vs. 
good coolers.  
 For the oxidative challenge study, to evaluate the effects of our FeCl2 and H2O2 
oxidative challenge treatment, a matched pairs analysis was used due to the fact that the 
same sample was analyzed twice—Both with and without the oxidative challenge 
treatment. To analyze potential differences in the way that sperm from control stallions 
and DHA/Vit E/Sel treated stallions handled the oxidative stress imposed upon them, a 
one-way ANOVA was used to compare the percent increase in positive (oxidative 
stressed) cells.  
 
3.5 Results 
 
For the initial DHA study, there was a significant overall time effect 
demonstrated, however no significant interaction was seen between time and group 
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(control/treated), or between time, group, and period (pre-/treatment). Therefore, 
averaged over all time points (0, 24, 48), total (Table 1) and progressive (Table 2) 
motility values for control stallions show no statistically significant change between the 
two groups (control/treated) but total and progressive motility values for the treated 
stallions increased significantly from the pre- to treatment period. However, no increase 
in total sperm number was demonstrated between the pre- and treatment periods in either 
group (Table 3); in fact a decrease in total sperm numbers in both groups was 
demonstrated, presumably due to normal seasonal changes in sperm parameters.  
In cooled semen, when DHA/Vit E/Sel treated stallions with <40% progressive 
motility (poor coolers) (n=3) were evaluated in comparison to treated stallions with 
>40% progressive motility (good coolers) (n=3), there was a significant improvement in 
total and progressive motility in poor coolers (p<0.02) following the treatment period, as 
opposed to good coolers, which had similar parameters between the pre- and treatment 
periods. This effect was demonstrated in poor coolers specifically at the 48-hour cooled 
time point.   
For frozen semen, there was no effect of time (0 and 30 min), thus data were 
summarized over time. Treatment did not significantly improve sperm total motility 
(Table 4), progressive motility (Table 5), viability (Table 6), mitochondrial membrane 
potential (Table 6), lipid peroxidation (Table 6), acrosomal status (Table 6), or membrane 
fluidity (Table 6) from the pre- to treatment periods.   
Results for the oxidative challenge study proved that treatment with the FeCl2 and 
H2O2 oxidative challenge was effective at inducing oxidative stress to the sperm 
membrane in both control and DHA/Vit E/Sel treated stallions (Figure 1). The oxidative 
challenge treatment was highly significant in both groups. For control stallions, when 
analyzed between control (not treated with the oxidative challenge) and treated sperm, p-
value < 0.03. For DHA/Vit E/Sel treated stallions, when analyzed between the same 
parameters, p-value < 0.008.  
However, there does not appear to be a significant difference in the way the 
control stallion sperm and the DHA/Vit E/Sel treated stallion sperm handled the oxidative 
damage (Figure 2). The oxidative challenge treatment appeared to affect both control and 
treated stallion sperm equally.  
42 
 
Table 1 
Effect of Feeding a Yeast-Based Supplement Containing 15g DHA from a 
Heterotrophically Grown Microalgae, 1000 IU Vitamin E and 2mg Selenium as 
Selenized Yeast on Total Motility in Fresh and Cooled Sperm (Mean and Standard Error)  
Total Motility 
Semen Sample Control Supplemented 
Pre-Treatment  63.1a, b ± 2.1 53.7b ± 2.5 
Treatment 64.5a, b ± 1.9 59.7a ± 2.0 
Analysis based on last 3 ejaculates of each of 12 stallions during the pre- treatment and 
treatment period, averaged over time (0, 24, 48) 
a,bMeans bearing different superscripts are significantly different 
 
Table 2 
Effect of Feeding a Yeast-Based Supplement Containing 15g DHA from a 
Heterotrophically Grown Microalgae, 1000 IU Vitamin E and 2mg Selenium as 
Selenized Yeast on Progressive Motility in Fresh and Cooled Sperm (Mean and Standard 
Error)  
Progressive Motility 
Semen Sample Control Supplemented 
Pre-Treatment  56.6a, b ± 2.3 48.5b ± 2.6 
Treatment 56.6a, b ± 2.3 54.9a ± 2.1 
Analysis based on last 3 ejaculates of each of 12 stallions during the pre- treatment and 
treatment period, averaged over time (0, 24, 48) 
a,b Means bearing different superscripts are significantly different 
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Table 3 
Effect of Feeding a Yeast-Based Supplement Containing 15g DHA from a 
Heterotrophically Grown Microalgae, 1000 IU Vitamin E and 2mg Selenium as 
Selenized Yeast on Total Sperm Numbers in Fresh Semen (Mean and Standard Error)  
Total Sperm 
Semen Sample Control Supplemented 
Pre-Treatment  12.2a  ± 0.8 11.1
a, b ± 1.1 
Treatment  8.5b, c ± 0.6 8.2c ± 1.1 
Analysis based on last 3 ejaculates of each of 12 stallions during the pre- treatment and 
treatment period 
a,b Means bearing different superscripts are significantly different 
 
 
Table 4 
Effect of Feeding a Yeast-Based Supplement Containing 15g DHA from a 
Heterotrophically Grown Microalgae, 1000 IU Vitamin E and 2mg Selenium as 
Selenized Yeast on Total Motility (Mean and Standard Error) in Frozen Semen  
Total Motility 
Semen Sample Control Supplemented 
Pre-Treatment 33.7 ± 2.8 38.2 ± 7.9 
Treatment 40.1 ± 4.4 33.0 ± 5.4 
Analysis based on last two ejaculates of each of 12 stallions during the pre- treatment and 
treatment period, averaged over time (0 and 30 min) 
*No significant differences were demonstrated 
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Table 5 
Effect of Feeding a Yeast-Based Supplement Containing 15g DHA from a 
Heterotrophically Grown Microalgae, 1000 IU Vitamin E and 2mg Selenium as 
Selenized Yeast on Progressive Motility (Mean and Standard Error) in Frozen Semen  
Progressive Motility 
Semen Sample Control Supplemented  
Pre-Treatment 22.7 ± 3.4 27.7 ± 7.8 
Treatment 28.3 ± 4.5 26.3 ± 4.4 
Analysis based on last two ejaculates of each of 12 stallions during the pre- treatment and 
treatment period, averaged over time (0 and 30 min) 
*No significant differences were demonstrated 
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Table 6 
Effect of Feeding a Yeast-Based Supplement Containing 15g DHA from a 
Heterotrophically Grown Microalgae, 1000 IU Vitamin E and 2mg Selenium as 
Selenized Yeast on Viability, Mitochondrial Membrane Potential (MMP), Lipid 
Peroxidation, Acrosome Intactness, and Membrane Fluidity (Mean and Standard Error) in 
Frozen Semen  
Parameter 
Measured 
Semen Sample Control Supplemented 
Viability 
(YoPro/PI) 
Pre-Treatment  34.1 ± 3.8 40.4 ± 3.5 
Treatment  43.5 ± 3.1 46.8 ± 2.5 
MMP (JC-1) Pre-Treatment 33.4 ± 3.3 34.4 ± 3.4 
Treatment 7.1 ± 1.3 8.2 ± 1.5 
Lipid Perox 
(BODIPY C11 
581/591) 
Pre-Treatment 18.3 ± 1.8 18.1 ± 1.6 
Treatment 17.9 ± 1.9 16.8 ± 2.3 
Acrosome 
Intactness (FITC 
PNA/PI) 
Pre-Treatment 23.3 ± 4.1 27.7 ± 3.3 
Treatment 39.4 ± 4.1 47.5 ± 3.7 
Membrane Fluidity 
(Merocyanine 540) 
Pre-Treatment 11.7 ± 2.9 8.2 ± 1.7 
Treatment 15.3 ± 2.8 18.6 ± 2.4 
Analysis based on last two ejaculates of each of 12 stallions during the treatment period 
*No significant differences were demonstrated 
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Figure 1 
Effect of Feeding a Yeast-Based Supplement Containing 15g DHA from a 
Heterotrophically Grown Microalgae, 1000 IU Vitamin E and 2mg Selenium as 
Selenized Yeast on Total Motility in Poor vs. Good Coolers at 24 hours of Cooling 
 
 
Figure 2 
Effect of Feeding a Yeast-Based Supplement Containing 15g DHA from a 
Heterotrophically Grown Microalgae, 1000 IU Vitamin E and 2mg Selenium as 
Selenized Yeast on Progressive Motility in Poor vs. Good Coolers at 24 hours of Cooling 
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Figure 3 
Effect of Feeding a Yeast-Based Supplement Containing 15g DHA from a 
Heterotrophically Grown Microalgae, 1000 IU Vitamin E and 2mg Selenium as 
Selenized Yeast on Total Motility in Poor vs. Good Coolers at 48 hours of Cooling  
 
 
 
Figure 4  
Effect of Feeding a Yeast-Based Supplement Containing 15g DHA from a 
Heterotrophically Grown Microalgae, 1000 IU Vitamin E and 2mg Selenium as 
Selenized Yeast on Progressive Motility in Poor vs. Good Coolers at 48 hours of Cooling 
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Figure 5 
Effect of Oxidative Challenge Treatment on Control and DHA/Vit E/Sel Treated Stallion 
Sperm 
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Figure 6 
Effect of Oxidative Challenge Treatment on Control vs. DHA/Vit E/Sel Treated Stallion 
Sperm 
 
 
3.6 Discussion 
 
Our findings demonstrate that feeding a supplement containing 15g 
docosahexaenoic acid from a heterotrophically grown microalgae, 1000 IU vitamin E and 
2mg selenium as selenized yeast can significantly improve both the total and progressive 
motility of fresh (T0) and cooled (T24, T48) stallion sperm. DHA supplementation in this 
study, as well as others [12], has been demonstrated to give spermatozoa improved ability 
to withstand cooling stresses.  A 2005 study by Brinsko et al. demonstrated that sperm 
from stallions fed a DHA-containing product showed higher velocity and straighter 
trajectory after 24 hours of cooling [12]. After 48 hours of cooling, significant increases 
in total motility, progressive motility, and rapid sperm motility were seen in stallions fed 
DHA [12]. Feeding the DHA supplement also resulted in a significant increase in sperm 
DHA levels, as well as a 50% increase in the ratio of DHA to DPA in sperm [12]. 
Brinsko et al. noted that there may have been an even further increase in semen 
parameters had they added other ingredients to the ration, as it has been demonstrated 
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that the response to the feeding of omega-3 fatty acids is dependent upon the ratio of 
omega-3 to omega-6 fatty acids, and a diet high in cereal grains is rich in omega-6 fatty 
acids.  
Unpublished observations in a study by Squires et al. in 2006 noted a tendency 
for significant improvement in the total percentage of progressively motile sperm per 
ejaculate at both fresh and 24-hour cooled time points when fed a fish oil and microalgae 
based DHA supplement. However, although a slight improvement was demonstrated, the 
Squires et al. study did not note a significant improvement in total percentage of 
progressively motile sperm per ejaculate in semen cooled for 48-hours, or in 
cryopreserved semen. An important point to note is that the two above studies employed 
the use of a DHA supplement that was derived from a combination of microalgae and 
fish oil-based sources. It is possible that the effectiveness of the DHA supplement seen in 
these studies was due to the fact that the product contained either all, or some, fish oil-
derived DHA.   
Differences in fatty acid composition of the sperm plasma membrane, such as a 
decreased amount of DHA in the membrane, have been shown to be involved in defective 
human spermatozoa [13]. In addition, it has been found in humans that the DHA content 
in sperm membranes is positively correlated with progressive motility, and lower levels 
of DHA were seen in the sperm of infertile men as compared to fertile men [14]. In pigs, 
supplementation with n-3 fatty acids increased both sperm quality [15] and sperm 
numbers [16]. There has been some evidence that feeding fish oil to boars increases DHA 
in the testis and increases steroid production [17], and these alterations demonstrate the 
potential to affect sperm production. It has also been shown that feeding fish oil to rams 
helped curb the seasonal decline in sperm production and semen quality [18]. Studies in 
the stallion are lacking, but it has been implied that infertile or sub-fertile stallions are 
potentially lacking high DHA content in their sperm membrane, and that those stallions 
that have semen that cools or freezes poorly also have reduced levels of DHA in their 
sperm [12].  
The microalgae-based product in this study was very palatable. All stallions 
accepted the supplement within the first three days of feeding. The source of DHA fed in 
previous studies with stallions was primarily fish oil based. One of the common 
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complaints of feeding fish oil to stallions is the refusal of some stallions to eat any of the 
DHA supplement (Squires, unpublished).  
Response to DHA varies stallion to stallion, and individual differences in stallion 
response were seen in this study, similar to previous studies. An important consideration 
is that previous studies have demonstrated that stallions with low initial sperm motility 
seem to have a better response to DHA supplementation than stallions with initially high 
motility; therefore higher improvement rates are seen in stallions with initially low 
motility after supplementation with DHA. Brinsko categorized stallions as having semen 
that cooled poorly, and when they examined this sub-group of stallions they were able to 
show a higher improvement in sperm motion parameters in the DHA treated group of 
stallions [12]. Sperm concentration and motility were especially increased in this sub-
group of stallions [12]. Our study demonstrated similar results to the Brinsko study—
Stallions with <40% progressive motility after 48 hours of cooling following the 
treatment period showed a significant improvement in total and progressive motilities as 
compared to stallions with >40% motility.  
   Our study provided the treated group of stallions with 15g of DHA daily, as well 
as 2 mg Selenium and 1000 IU Vitamin E. The exact quantity of the DHA provided in the 
supplement used in the Brinsko study was not provided, but the supplement was reported 
to contain 30% omega-3 fatty acid, of which contained a minimum of 25% DHA [12]. It 
is possible that the fish oil-based DHA supplement fed in the 2005 Brinsko study 
contained a higher level of DHA than the microalgae-based product our study employed, 
and could be a possible reason that their study demonstrated significance in frozen 
semen, while our study did not. However, the study done by Squires (unpublished) also 
contained 15g of DHA, and demonstrated a tendency for significant improvement of the 
progressive motility of fresh semen, as well as in cooled semen at the 24-hour time point.   
The fact that no significant effect was seen on the stallion sperm in regards to the 
frozen parameters measured was unexpected, given the data in other equine studies as 
well as data from studies done on other species.  Sperm membrane fluidity is necessary 
for motility, and DHA has been demonstrated to significantly alter many basic properties 
of the membrane, including fluidity. Fluidity is an extremely important quality for the 
spermatozoa to have throughout the freezing process, as the integrity and fluidity of the 
52 
 
sperm plasma membrane has a direct effect on its ability to withstand osmotic and 
oxidative stress, both of which are essential to sperm viability.  
Although studies in the stallion relating to the specific frozen semen parameters 
we evaluated, including sperm viability, mitochondrial membrane potential, lipid 
peroxidation, acrosomal status, and membrane fluidity are lacking, similar studies have 
been conducted in other species. For example, in monkeys, 99% of total sperm DHA 
content can be found in the tail, suggesting that DHA density in the sperm tail is likely 
related to fluidity and flexibility [19]. Further studies have demonstrated the effects of 
DHA on membrane structure and function [5, 20]. However, unlike observations reported 
in previous research [12], our findings did not demonstrate any significant improvement 
in post-thaw sperm parameters. Parameters measured included sperm viability, 
mitochondrial membrane potential, acrosomal status, lipid peroxidation, and membrane 
fluidity; none of these parameters showed a significant difference between control and 
treated stallions between the pre- and treatment periods.    
 Our study lasted 60 days, and stallions were collected for semen evaluation 
starting at day 45 of treatment. Due to the fact that spermatogenesis in the stallion takes 
57 days, it may have been more beneficial to evaluate the stallion semen starting on day 
60, rather than starting on day 45. Although the last three ejaculates from each stallion 
were evaluated for use in the statistical results, providing samples from day 60, it is 
possible that a later collection may have demonstrated significant results. Previous 
studies fed the DHA supplement for 90 days, which may be the cause behind the varying 
results; it is possible that the last 30 days of feeding the supplement provided more time 
for DHA to incorporate into the sperm membrane and cause the significant improvement 
in frozen parameters, which our study did not demonstrate.   
 Due to the availability of stallions, our study began in July and was completed in 
October. Thus, we anticipated the seasonal drop in sperm numbers from July to October 
due to changes in the length of daylight and hormonal changes. This was quite evident in 
the control stallions. We anticipated that the drop in sperm numbers would be less for the 
DHA/Vitamin E/Selenium treated stallions, similar to the study in rams where DHA 
prevented the normal seasonal changes. Although there was a seasonal decline in sperm 
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numbers in both control and treated stallions, supplementation with DHA had no effect 
on sperm numbers 
The addition of the antioxidants vitamin E and selenium to the DHA supplement 
was done to minimize lipid peroxidation in the sperm membrane. Once the lipid 
peroxidation cascade begins, a decrease in sperm viability and fertilization capabilities is 
demonstrated. A study done in 2011 showed that dietary supplementation with the 
antioxidants selenium, vitamin E, and zinc resulted in a significant increase in sperm 
average path velocity, straightness, viability, and total seminal plasma antioxidant levels, 
as well as a significant improvement in progressive motility and a decrease in abnormal 
sperm morphology in antioxidant-treated stallions versus controls [21]. They concluded 
that dietary antioxidant supplementation with selenium, Vitamin E, and zinc may have 
decreased the susceptibility of spermatozoa to damage induced by reactive oxygen 
species, or increased the ability of seminal plasma to reduce the oxidative stress [21]. In 
bull sperm, the combination of omega-3 fatty acids and Vitamin E changed the sperm 
membrane composition and improved the freezability of sperm [9]. Adding selenium as 
an antioxidant may also be beneficial to spermatozoa when given in combination with 
DHA, as the selenium content of equine spermatozoa has been found to positively 
correlate with progressive motility and fertility rate [22]. Ultimately, our study employed 
the use of Vitamin E and selenium in order to potentially increase the effectiveness of the 
microalgae-based DHA supplement that we fed to the treated stallions.  
 As previously stated, multiple studies have demonstrated that after DHA 
supplementation, DHA does in fact incorporate into the sperm membrane [6]. Wood et al. 
(unpublished) analyzed the lipid composition of sperm from the current study and found 
that dietary DHA supplementation increased free DHA levels, as well as increased the 
levels of DHA-containing choline and ethanolamine plasmalogens and 
phosphatidylcholines in the sperm. This new lipidomic data, as well data from past 
studies in other species, supports the hypothesis that low DHA levels are possibly partly 
responsible for the poor viability of cryopreserved equine sperm. Thus, it is again 
surprising that our data did not show significant improvement in frozen semen 
parameters.   
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 The use of 8-hydroxy-2’-deoxyguanosine (8OHdG) as a biomarker for oxidative 
damage to spermatozoa in the oxidative challenge part of our study was based on 
previous studies that have demonstrated that the level of 8OHdG in DNA from tissues or 
cells can be used to record the balance between damage and repair [23]. 8OHdG is 
formed during reactive oxygen species damage to DNA and is a specific indicator of 
oxidative stress that is correlated with impaired mitochondrial membrane potential, 
superoxide generation, and impaired chromatin remodeling. Poor quality, low-density 
sperm, or defective sperm, have naturally more 8OHdG generation than healthy sperm. 
8OHdG is a useful marker of DNA damage, because it and its corresponding base, 8-
hydroxyguanine, represent about 5% of the total oxidized bases that are known to occur 
in DNA [24]. They can be measured with very high sensitivity using electrochemical 
detection [24], which is why the use of a flow cytometer was employed in the oxidative 
challenge part of our study. 
 Stressing the sperm with the oxidative challenge treatment consisting of FeCl2 
and H2O2 was effective at inducing significant oxidative damage to the sperm membrane, 
demonstrated on the flow cytometer. This specific assay employing the use of FeCl2 and 
H2O2 together has not to the author’s knowledge been previously documented in the 
stallion, thus this represents a novel and effective method of causing deliberate oxidative 
stress to the equine sperm membrane. However, no significant difference was noted in 
the ability of control stallion sperm versus DHA/Vit E/Sel treated stallion sperm in its 
ability to withstand oxidative stress. Both control and treated stallion sperm appeared to 
respond almost identically to the oxidative challenge treatment.  
 Ultimately, our findings show that stallions fed the 15g docosahexaenoic acid 
from a heterotrophically grown microalgae, 1000 IU vitamin E and 2mg selenium as 
selenized yeast supplement had improved sperm motility after 60 days of treatment upon 
evaluation of both fresh and cooled semen. This represents a novel DHA/vitamin 
E/selenium supplement that is palatable to a wide range of stallions. Finally, feeding a 
DHA, vitamin E, and selenium supplement can be effective in improving motility of both 
fresh and cooled stallion sperm; however cryopreserved spermatozoa were not affected.  
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Chapter Four: Summary and Conclusions 
 
 Supplementation of a yeast-based supplement containing 15g DHA from a 
heterotrophically grown microalgae, 1000 IU Vitamin E, and 2mg Selenium as selenized 
yeast enhanced the total and progressive motilities of both fresh and cooled stallion 
sperm. However, this supplementation did not appear to significantly affect total sperm 
numbers in fresh sperm, or parameters measured in cryopreserved spermatozoa. When 
frozen/thawed sperm were evaluated for sperm viability, mitochondrial membrane 
potential, lipid peroxidation, acrosomal status, and membrane fluidity, the yeast-based 
supplement containing microalgal DHA, Vitamin E, and Selenium did not appear to 
cause significant changes in any of the parameters measured.  
The lipidomics study by Wood et al done in conjunction with our initial study 
demonstrated that dietary supplementation with the same yeast-based supplement 
increased free DHA levels, as well as increased the levels of DHA-containing choline and 
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ethanolamine plasmalogens, and phosphatidylcholines in the sperm. Thus, it was 
unexpected that we did not see a significant improvement in the frozen parameters 
measured, as DHA was demonstrated to incorporate into the sperm membrane, and 
previous research in other species has shown improvements in similar parameters 
following a membrane incorporation of DHA.  
Future directions could include a study that both begins and ends during the warm 
summer months, so that seasonality is not a confounding variable. Also, a longer 
treatment period with a DHA supplement could be employed in order to see if treatment 
period length was a factor in the insignificance of our frozen semen results. Other future 
studies could provide higher levels of DHA to the stallions as well, or minimize the 
amount of omega-6 fatty acids in the diet in conjunction with supplementation of DHA. 
The use of different antioxidants could also be employed to see if additional antioxidant 
supplementation along with docosahexaenoic acid supplementation would improve the 
parameters measured in cryopreserved spermatozoa. Finally, potentially beneficial 
research that could be performed would be a study in which control stallions would be 
fed an antioxidant supplement containing simply Vitamin E and Selenium, while the 
DHA-treated stallions would be fed a supplement containing both of these antioxidants as 
well as DHA. 
  
59 
 
Appendices 
 
 
Appendix 1: Effect of Feeding a Yeast-Based Supplement Containing 15g DHA from a 
Heterotrophically Grown Microalgae, 1000 IU Vitamin E and 2mg Selenium as 
Selenized Yeast on Total Motility in Fresh and Cooled Sperm 
 
 
 
Appendix 2: Effect of Feeding a Yeast-Based Supplement Containing 15g DHA from a 
Heterotrophically Grown Microalgae, 1000 IU Vitamin E and 2mg Selenium as 
Selenized Yeast on Progressive Motility in Fresh and Cooled Sperm 
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Appendix 3: Time Effect of Treatment in Fresh/Cooled Semen (Least Squared Means ± 
S.E.M) 
 T0 T24 T48 p-value 
Total Motility 70.90 ± 0.07 55.68 ± 0.07 47.44 ± 0.07 P<0.001 
Progressive 
Motility 
64.13 ± 0.09 48.48 ± 0.09 40.15 ± 0.09 P<0.001 
 
 
Appendix 4: Fresh and Cooled Semen Interaction P-Values 
Fresh/Cooled Semen P-values  
 Total Motility Progressive Motility 
Time 0.0001 0.0001 
Treatment 0.293 0.594 
Period 0.354 0.803 
Time*Treatment 0.853 0.942 
Time*Period 0.363 0.156 
Treatment*Period 0.022 0.014 
Treatment*Ejaculate*Period 0.632 0.910 
 
 
 
Appendix 5: Frozen Semen Interaction P-Values 
Frozen Semen P-values 
 Total 
Motility 
(T0) 
Progressive 
Motility (T0) 
Total 
Motility 
(T30) 
Progressive 
Motility 
(T30) 
Ejaculate 0.216 0.752 0.441 0.090 
Period 0.185 0.539 0.222 0.174 
Ejaculate*Period 0.003 0.068 0.198 0.844 
Treatment 0.906 0.753 0.994 0.979 
Ejaculate*Treatment 0.592 0.488 0.912 0.890 
Period*Treatment 0.224 0.815 0.376 0.244 
Ejaculate*Period*Treatment 0.452 0.431 0.744 0.088 
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Appendix 6: Raw Data—Fresh, Pre-Treatment Period 
  
 
Subject Date Vol  Concentration TM PM TS # 
K113 7/15/14 47 233 83 78 10.9 
L111 7/15/14 91 257 69 66 23.3 
L118 7/15/14 78 227 53 39 17.7 
N118 7/15/14 78 137 75 68 10.6 
N119 7/14/14 72 272 82 78 19.5 
N120 7/14/14 73 211 61 57 15.4 
N122 7/15/14 43 291 81 75 12.5 
N104 7/14/14 35 664 54 51 23.2 
N105 7/14/14 24 378 24 19 9 
O103 7/14/14 65 104 82 78 6.7 
O113 7/14/14 60 234 72 66 14 
O114 7/14/14 102 382 75 73 38.9 
       
 
Subject Date Vol Concentration TM PM TS # 
K113 7/17/14 65 438 83 79 28.4 
L111 7/17/14 95 217 70 65 20.6 
L118 7/17/14 73 202 61 57 14.7 
N118 7/17/14 60 178 71 67 10.6 
N119 7/16/14 56 207 83 79 11.5 
N120 7/16/14 65 148 58 50 9.6 
N122 7/17/14 123 135 80 75 16.6 
N104 7/16/14 45 207 69 66 9.3 
N105 7/16/14 23 373 39 36 8.5 
O103 7/16/14 48 196 70 63 9.4 
O113 7/16/14 50 254 72 66 12.7 
O114 7/16/14 90 276 75 67 24.8 
 
Subject Date Vol Concentration TM PM TS # 
K113 7/19/14 58 315 85 85 18.2 
L111 7/19/14 70 269 76 73 18.8 
L118 7/19/14 100 81 60 54 8.1 
N118 7/19/14 46 191 78 75 8.7 
N119 7/18/14 39 519 85 83 20.2 
N120 7/18/14 67 171 49 45 11.4 
N122 7/19/14 170 119 77 67 20.2 
N104 7/18/14 29 345 61 55 10.1 
N105 7/18/14 29 248 64 55 7.1 
O103 7/18/14 17 578 61 57 9.8 
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O113 7/18/14 41 330 74 73 13.5 
O114 7/18/14 85 261 71 65 22.1 
 
Subject Date Vol Concentration TM PM TS # 
K113 7/21/14 64 293 73 67 18.7 
L111 7/21/14 100 191 68 63 19.1 
L118 7/21/14 77 117 45 35 9 
N118 7/21/14 38 220 79 76 8.3 
N119 7/20/14 37 427 70 69 15.7 
N120 7/20/14 60 176 38 36 10.5 
N122 7/21/14 98 153 83 78 14.9 
N104 7/20/14 32 534 62 57 17 
N105 7/20/14 44 186 60 53 8.1 
O103 7/20/14 33 531 75 72 17.5 
O113 7/20/14 56 267 75 69 14.9 
O114 7/20/14 90 219 71 69 19.7 
 
Subject Date Vol Concentration TM PM TS # 
K113 7/23/14 65 272 74 71 17.6 
L111 7/23/14 61 299 77 75 18.2 
L118 7/23/14 56 110 71 70 6.1 
N118 7/23/14 53 193 74 61 10.2 
N119 7/22/14 29 497 85 83 14.4 
N120 7/22/14 49 162 45 37 7.9 
N122 7/23/14 149 127 81 78 18.9 
N104 7/22/14 70 180 63 56 12.6 
N105 7/22/14 31 223 69 66 6.9 
O103 7/22/14 31 173 63 59 5.3 
O113 7/22/14 84 169 72 72 14.2 
O114 7/22/14 82 162 69 66 13.2 
 
Subject Date Vol Concentration TM PM TS # 
K113 7/25/14 60 153 77 73 9.1 
L111 7/25/14 80 199 72 64 15.9 
L118 7/25/14 63 177 64 61 11.1 
N118 7/25/14 54 151 73 67 8.1 
N119 7/24/14 44 318 87 84 13.9 
N120 7/24/14 37 212 39 38 7.8 
N122 7/25/14 83 199 81 80 16.5 
N104 7/24/14 63 275 61 59 17.3 
N105 7/24/14 31 228 63 51 7 
O103 7/24/14 24 554 76 71 13.6 
O113 7/24/14 38 334 82 72 12.6 
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O114 7/24/14 88 190 71 69 16.7 
       
 
Subject Date Vol Concentration TM PM TS # 
K113 7/27/14 58 327 65 60 18.9 
L111 7/27/14 45 178 71 66 8 
L118 7/27/14 52 223 67 65 11.5 
N118 7/27/14 32 253 74 69 8.1 
N119 7/26/14 71 186 85 81 13.2 
N120 7/26/14 50 120 42 39 6 
N122 7/27/14 64 197 84 82 12.6 
N104 7/26/14 35 272 60 58 9.5 
N105 7/26/14 20 323 65 62 6.4 
O103 7/26/14 23 338 74 67 7.7 
O113 7/26/14 45 331 85 79 14.8 
O114 7/26/14 89 223 65 62 19.8 
 
       
 
Appendix 7: Raw Data—Fresh, Treatment Period 
       
Subject Date Vol Concentration TM PM TS # 
K113 9/23/14 55 460 71 67 25.3 
L111 9/23/14 64 262 74 67 16.7 
L118 9/23/14 30 264 69 65 7.9 
N118 9/23/14 58 216 58 44 12.5 
N119 9/24/14 57 224 75 72 12.7 
N120 9/23/14 59 159 32 23 9.3 
N122 9/23/14 68 196 71 67 13.3 
N104 9/24/14 19 241 35 26 4.5 
N105 9/24/14 33 164 48 43 5.4 
O103 9/24/14 50 537 58 53 26.8 
O113 9/24/14 69 206 66 60 14.2 
O114 9/24/14 68 485 75 72 32.9 
       
       
Subject Date Vol Concentration TM PM TS # 
K113 9/25/14 44 343 83 81 15 
L111 9/25/14 77 184 57 53 14.1 
L118 9/25/14 56 50 64 55 2.8 
N118 9/25/14 58 225 75 69 13 
N119 9/26/14 31 302 78 71 9.3 
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N120 9/25/14 58 162 43 40 9.3 
N122 9/25/14 153 144 76 69 22 
N104 9/26/14 52 137 60 45 7.1 
N105 9/26/14 42 223 65 62 9.3 
O103 9/26/14 38 258 78 69 9.8 
O113 9/26/14 51 237 80 77 12 
O114 9/26/14 48 518 77 71 24.8 
       
Subject Date Vol Concentration TM PM TS # 
K113 9/27/14 25 416 79 73 10.4 
L111 9/27/14 37 499 79 76 18.4 
L118 9/27/14 65 133 71 65 8.6 
N118 9/27/14 34 220 76 69 7.4 
N119 9/28/14 43 200 81 78 8.6 
N120 9/27/14 20 216 45 41 4.3 
N122 9/27/14 59 229 79 76 13.5 
N104 9/28/14 15 253 64 52 3.7 
N105 9/28/14 33 209 71 62 6.8 
O103 9/28/14 34 214 78 73 7.2 
O113 9/28/14 35 344 80 76 12 
O114 9/28/14 34 678 65 63 23 
       
Subject Date Vol Concentration TM PM TS # 
K113 9/29/14 13 592 83 80 7.6 
L111 9/29/14 45 316 73 66 14.2 
L118 9/29/14 32 249 75 60 7.9 
N118 9/29/14 34 265 81 79 9 
N119 9/30/14 42 138 79 76 5.8 
N120 9/29/14 24 273 51 45 6.5 
N122 9/29/14 54 230 85 84 12.4 
N104 9/30/14 40 107 51 46 4.2 
N105 9/30/14 40 201 63 59 8 
O103 9/30/14 36 191 76 71 6.9 
O113 9/30/14 53 173 68 61 9.2 
O114 9/30/14 35 518 77 71 24.8 
Subject Date Vol Concentration TM PM TS # 
K113 10/1/14 32 365 76 73 11.7 
L111 10/1/14 31 425 73 71 13.2 
L118 10/1/14 55 92 75 58 5.1 
N118 10/1/14 38 185 77 74 7 
N119 10/2/14 27 301 84 83 8.1 
N120 10/1/14 27 181 59 53 6.7 
N122 10/1/14 156 97 81 76 15.1 
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N104 10/2/14 45 122 63 57 5.4 
N105 10/2/14 37 197 69 67 7.3 
O103 10/2/14 29 163 72 70 4.7 
O113 10/2/14 35 255 80 75 8.9 
O114 10/2/14 90 195 80 77 17.6 
       
Subject Date Vol Concentration TM PM TS # 
K113 10/3/14 44 195 71 68 8.6 
L111 10/3/14 38 406 76 75 15.4 
L118 10/3/14 43 210 74 65 9 
N118 10/3/14 50 178 69 64 8.9 
N119 10/4/14 42 154 84 81 6.5 
N120 10/3/14 33 141 46 42 4.6 
N122 10/3/14 57 81 79 63 4.6 
N104 10/4/14 14 148 66 57 2 
N105 10/4/14 34 174 70 68 5.9 
O103 10/4/14 47 159 74 73 3.5 
O113 10/4/14 29 283 86 82 8.2 
O114 10/4/14 50 273 69 66 13.7 
       
Subject Date Vol Concentration TM PM TS # 
K113 10/5/14 36 284 72 70 10.4 
L111 10/5/14 59 181 71 68 10.6 
L118 10/5/14 44 186 66 59 8.1 
N118 10/5/14 45 133 78 73 5.9 
N119 10/6/14 36 204 85 84 7.3 
N120 10/5/14 27 206 52 45 5.5 
N122 10/5/14 35 274 81 76 9.5 
N104 10/6/14 19 171 64 58 3.2 
N105 10/6/14 33 191 75 72 6.3 
O103 10/6/14 35 209 78 74 7.3 
O113 10/6/14 39 243 80 76 9.5 
O114 10/6/14 36 422 75 74 15.1 
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Appendix 8: Raw Data, Cooled 24hr, Pre-Treatment Period 
Subject Date 
Total 
Motility 
Progressive 
Motility 
K113 7/23/14 67 61.5 
K113 7/25/14 66 59 
K113 7/27/14 69 64 
L111 7/23/14 72 68.5 
L111 7/25/14 73 66 
L111 7/27/14 73 63.5 
L118 7/23/14 34 17.5 
L118 7/25/14 39 32.5 
L118 7/27/14 51 46 
N118 7/23/14 39 30.5 
N118 7/25/14 57 47 
N118 7/27/14 66 57.5 
N119 7/22/14 55 46 
N119 7/24/14 67 59 
N119 7/26/14 64 52 
N120 7/22/14 21 14 
N120 7/24/14 25 23 
N120 7/26/14 13 9 
N122 7/23/14 69 59 
N122 7/25/14 69 65 
N122 7/27/14 71 67 
N104 7/22/14 50 40.5 
N104 7/24/14 45 38.5 
N104 7/26/14 53 45.5 
N105 7/22/14 31 25 
N105 7/24/14 43 33.5 
N105 7/26/14 54 48 
O103 7/22/14 60 59.5 
O103 7/24/14 63 59 
O103 7/26/14 70 65.5 
O113 7/22/14 62 54.5 
O113 7/24/14 71 65 
O113 7/26/14 70 65.5 
O114 7/22/14 64 61 
O114 7/24/14 60 55 
O114 7/26/14 59 54.5 
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Appendix 9: Raw Data, Cooled 48hr, Pre-Treatment Period 
Date 
Total 
Motility 
Progressive 
Motility 
7/23/14 56 49 
7/25/14 62 53 
7/27/14 57 52 
7/23/14 64 58 
7/25/14 67 63 
7/27/14 66 55 
7/23/14 20 16 
7/25/14 28 25 
7/27/14 37 25 
7/23/14 37 28 
7/25/14 48 38 
7/27/14 53 46 
7/22/14 65 56 
7/24/14 66 61 
7/26/14 64 54 
7/22/14 16 9.5 
7/24/14 16 12 
7/26/14 8 2.5 
7/23/14 39 30 
7/25/14 55 51 
7/27/14 67 60 
7/22/14 37 31 
7/24/14 34 32 
7/26/14 46 35 
7/22/14 34 23 
7/24/14 24 14 
7/26/14 48 45 
7/22/14 52 49 
7/24/14 77 73 
7/26/14 75 73 
7/22/14 43 36 
7/24/14 70 61 
7/26/14 65 59 
7/22/14 53 49 
7/24/14 51 46 
7/26/14 58 49 
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Appendix 10: Raw Data, Cooled 24hr, Treatment Period 
Subject Date 
Total 
Motility 
Progressive 
Motility 
K113 10/1/14 78 74 
K113 10/3/14 74 65 
K113 10/5/14 72 69 
L111 10/1/14 75 69 
L111 10/3/14 74 69 
L111 10/5/14 65 58 
L118 10/1/14 45 38 
L118 10/3/14 54 52 
L118 10/5/14 51 43 
N118 10/1/14 66 55 
N118 10/3/14 62 54 
N118 10/5/14 68 60 
N119 10/2/14 62 54 
N119 10/4/14 69 62 
N119 10/6/14 45 34 
N120 10/1/14 42 35 
N120 10/3/14 26 23 
N120 10/5/14 37 26 
N122 10/1/14 61 55 
N122 10/3/14 52 40 
N122 10/5/14 73 66 
N104 10/2/14 44 35 
N104 10/4/14 55 49 
N104 10/6/14 48 43 
N105 10/2/14 65 62 
N105 10/4/14 64 59 
N105 10/6/14 54 47 
O103 10/2/14 67 66 
O103 10/4/14 72 68 
O103 10/6/14 73 70 
O113 10/2/14 72 64 
O113 10/4/14 72 66 
O113 10/6/14 45 40 
O114 10/2/14 71 63 
O114 10/4/14 67 68 
O114 10/6/14 49 43 
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Appendix 11: Raw Data, Cooled 48hr, Treatment Period 
Date 
Total 
Motility 
Progressive 
Motility 
10/1/14 66 62 
10/3/14 63 58 
10/5/14 57 53 
10/1/14 66 62 
10/3/14 68 65 
10/5/14 64 59 
10/1/14 28 14 
10/3/14 46 35 
10/5/14 46 39 
10/1/14 59 53 
10/3/14 58 50 
10/5/14 54 48 
10/2/14 60 53 
10/4/14 61 54 
10/6/14 42 35 
10/1/14 39 30 
10/3/14 17 11 
10/5/14 34 31 
10/1/14 53 43 
10/3/14 30 21 
10/5/14 67 63 
10/2/14 38 34 
10/4/14 44 40 
10/6/14 45 36 
10/2/14 59 57 
10/4/14 62 58 
10/6/14 48 44 
10/2/14 67 60 
10/4/14 64 60 
10/6/14 69 63 
10/2/14 63 56 
10/4/14 68 61 
10/6/14 44 34 
10/2/14 59 53 
10/4/14 55 53 
10/6/14 40 35 
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Appendix 12: Raw Data, Frozen Sperm Motilities 
Stallion 
ID Date Ejaculate Group 
TM 
(T0) 
PM 
(T0) 
TM 
(T30) 
PM 
(T30) 
K113 7/23/14 1 CONTROL 40.44 16.29 42.58 31.42 
K113 7/25/14 2 CONTROL 41.47 31.33 23.14 16.81 
K113 7/27/14 3 CONTROL 50.24 44.63 39.38 19.5 
K113 10/1/14 1 CONTROL 36.17 19.23 28 14.02 
K113 10/3/14 2 CONTROL 57.17 35.93 54.47 34.99 
K113 10/5/14 3 CONTROL 44.54 34.35 50.62 39.04 
L111 7/23/14 1 TREATED 72.12 60 50.75 42.51 
L111 7/25/14 2 TREATED 60.45 53.77 49.47 42.6 
L111 7/27/14 3 TREATED 48.43 43.49 54.29 48.62 
L111 10/1/14 1 TREATED 60.2 43.74 54.24 29.64 
L111 10/3/14 2 TREATED 52.03 42.33 58.05 46.71 
L111 10/5/14 3 TREATED 62 41.48 71.64 54.26 
L118 7/23/14 1 CONTROL 39.04 23.39 16.05 7.15 
L118 7/25/14 2 CONTROL 20.09 9.55 18.87 7.46 
L118 7/27/14 3 CONTROL 18.06 8.22 18.97 7.83 
L118 10/1/14 1 CONTROL 17.36 7.32 11.36 5.68 
L118 10/3/14 2 CONTROL 21.54 9.29 29.99 14.82 
L118 10/5/14 3 CONTROL 25.84 11.92 34.69 18.28 
N104 7/22/14 1 TREATED 23.22 11.11 42.06 8.96 
N104 7/24/14 2 TREATED 18.92 8.72 17.79 7.22 
N104 7/27/14 3 TREATED 8.71 1.79 6.07 1.76 
N104 10/2/14 1 TREATED 18.45 6.9 12.44 2.58 
N104 10/4/14 2 TREATED 45.5 24.02 32.44 18.65 
N104 10/6/14 3 TREATED 26.4 16.17 28.49 13.74 
N105 7/24/14 1 TREATED 20.68 8.54 4.56 2 
N105 7/26/14 2 TREATED 28.61 21.87 5.26 2.1 
N105 10/2/14 1 TREATED 30.21 26.06 21.8 11.48 
N105 10/4/14 2 TREATED 35.24 25.59 23.1 14.52 
N105 10/6/14 3 TREATED 24.33 20.02 15.85 10.14 
N118 7/23/14 1 CONTROL 35.71 11.42 22.2 9.66 
N118 7/25/14 2 CONTROL 37.2 22.24 33.96 16.79 
N118 7/27/14 3 CONTROL 33.7 23.77 30.07 17.85 
N118 10/1/14 1 CONTROL 31.54 22.98 21.32 10.37 
N118 10/3/14 2 CONTROL 66.99 52.22 41.9 29.83 
N118 10/5/14 3 CONTROL 48.22 36.59 40.96 25.74 
N119 7/22/14 1 CONTROL 65.51 60.46 38.51 15.55 
N119 7/24/14 2 CONTROL 48.42 40.35 20.56 11.34 
N119 7/26/14 3 CONTROL 15.87 10.97 32.11 29.14 
N119 10/2/14 1 CONTROL 35.31 24.68 33.15 24.7 
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N119 10/4/14 2 CONTROL 46.22 32.55 32.6 25.17 
N119 10/6/14 3 CONTROL 28.25 14.17 18.36 12.85 
N120 7/22/14 1 TREATED 57.58 43.71 35.66 13.98 
N120 7/24/14 2 TREATED 30.69 17.22 21.25 14.11 
N120 7/26/14 3 TREATED 28.83 23.52 11.39 7.46 
N120 10/1/14 1 TREATED 40.98 28.79 15.1 10.33 
N120 10/3/14 2 TREATED 43.43 32.77 12.44 5.47 
N120 10/5/14 3 TREATED 40.04 34.09 24.77 16.25 
N122 7/23/14 1 CONTROL 31.24 24.16 50.81 43.61 
N122 7/25/14 2 CONTROL 37.71 33.77 38.7 33.15 
N122 7/27/14 3 CONTROL 41.79 37.31 39.33 31.7 
N122 10/1/14 1 CONTROL 70.29 58.01 39.96 29.44 
N122 10/3/14 2 CONTROL 50.35 38.59 44.15 32.6 
N122 10/5/14 3 CONTROL 65.8 58.07 58.67 46.87 
O103 7/22/14 1 TREATED 72.58 65.48 37.14 15.71 
O103 7/24/14 2 TREATED 21.62 14.18 45.37 29.2 
O103 7/26/14 3 TREATED 36.07 32.39 66.78 41.3 
O103 10/2/14 1 TREATED 22.09 12.59 41.49 32.22 
O103 10/4/14 2 TREATED 51.85 40.32 46.35 37.82 
O103 10/6/14 3 TREATED 57.5 34.74 50.77 33.89 
O113 7/22/14 1 CONTROL 32.5 20 21.53 1.53 
O113 7/24/14 2 CONTROL 27.98 15.09 46.16 32.59 
O113 7/26/14 3 CONTROL 27.8 22.1 36.56 28.59 
O113 10/2/14 1 CONTROL 43.18 32.05 58.23 49.75 
O113 10/4/14 2 CONTROL 41.14 35.09 29.04 20.95 
O113 10/6/14 3 CONTROL 48.21 34.64 38.86 26.23 
O114 7/24/14 1 TREATED 79.1 64.38 47.41 35.08 
O114 7/26/14 2 TREATED 60.91 44.84 58.9 53.79 
O114  10/2/14 3 TREATED 39.21 33.27 35.52 24.63 
O114  10/4/14 1 TREATED 43.78 33.96 26.59 20.32 
O114  10/6/14 2 TREATED 35.6 29.57 53.55 36.14 
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Appendix 13: Raw Data, Frozen Sperm Viability, Mitochondrial Membrane Potential, 
Lipid Peroxidation, Acrosome Intactness, Membrane Fluidity 
 
Stallion 
ID Viability 
High MMP 
(%) 
Lipid Perox 
(%) 
Acrosome intact 
(%) 
Memb Fluid 
(%) 
K113 0.26750 0.44850 0.23050 0.28100 0.11140 
K113 0.11670 0.19130 0.20800 0.10370 0.46530 
K113 0.38920 0.53920 0.14910 0.21360 0.06300 
K113 0.45310 0.03220 0.22130 0.26360 0.08010 
K113 0.37060 0.05670 0.23370 0.13120 0.00900 
K113 0.54910 0.06710 0.13050 0.58900 0.13220 
L111 0.57190 0.32590 0.19520 0.07690 0.00940 
L111 0.08410 0.17600 0.16770 0.05560 0.28070 
L111 0.28580 0.41630 0.12020 0.29460 0.09250 
L111 0.44860 0.00940 0.06250 0.42470 0.12300 
L111 0.32780 0.05200 0.17560 0.12440 0.01170 
L111 0.66010 0.06750 0.03860 0.54350 0.18880 
L118 0.24370 0.22980 0.28470 0.04920 0.01900 
L118 0.36210 0.12600 0.14400 0.15990 0.10800 
L118 0.20190 0.48700 0.12620 0.19870 0.08000 
L118 0.22830 0.01160 0.12130 0.21680 0.16340 
L118 0.27130 0.03130 0.21250 0.12980 0.01800 
L118 0.32880 0.01770 0.11700 0.28480 0.37760 
N104 0.35230 0.26960 0.10880 0.21640 0.03970 
N104 0.30230 0.23050 0.14960 0.25380 0.12660 
N104 0.44270 0.48340 0.11110 0.20310 0.03470 
N104 0.34290 0.02290 0.37800 0.39100 0.47440 
N104 0.38920 0.15110 0.19680 0.45760 0.26780 
N104 0.42860 0.10890 0.22360 0.37660 0.12640 
N105 0.55070 0.14670 0.17390 0.43390 0.06240 
N105 0.42160 0.26410 0.20930 0.27400 0.04570 
N105 0.44090 0.02270 0.08840 0.52200 0.23100 
N105 0.41840 0.09890 0.18060 0.62510 0.20790 
N105 0.50920 0.09150 0.17980 0.42890 0.08640 
N118 0.39770 0.32310 0.29040 0.05140 0.00850 
N118 0.05420 0.18750 0.11380 0.03360 0.13920 
N118 0.38870 0.59990 0.32590 0.22990 0.05720 
N118 0.46940 0.04790 0.16050 0.59720 0.11920 
N118 0.12680 0.11020 0.40290 0.09800 0.00960 
N118 0.55100 0.14590 0.20520 0.54870 0.31360 
N119 0.34760 0.38430 0.10440 0.17580 0.03090 
N119 0.45830 0.23030 0.11490 0.42110 0.05070 
N119 0.48250 0.29650 0.23580 0.41040 0.10160 
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N119 0.46510 0.00920 0.05750 0.51010 0.24430 
N119 0.45220 0.08440 0.14080 0.47330 0.15640 
N119 0.38070 0.19940 0.23240 0.34490 0.05250 
N120 0.23880 0.20440 0.13630 0.19200 0.03410 
N120 0.37340 0.40320 0.20730 0.29750 0.11660 
N120 0.27060 0.49130 0.25270 0.35820 0.14560 
N120 0.32930 0.03910 0.18860 0.45160 0.18440 
N120 0.27790 0.05410 0.37230 0.11100 0.02470 
N120 0.48400 0.05740 0.07430 0.45100 0.18330 
N122 0.45010 0.23800 0.24710 0.08820 0.01070 
N122 0.08670 0.15610 0.13480 0.06500 0.32610 
N122 0.56870 0.51230 0.21610 0.57030 0.22050 
N122 0.54050 0.03810 0.16320 0.32040 0.04830 
N122 0.46960 0.06350 0.24460 0.50570 0.16820 
N122 0.61680 0.10630 0.21550 0.59070 0.37360 
O103 0.44010 0.31300 0.12140 0.18670 0.03900 
O103 0.56270 0.23040 0.18260 0.46120 0.08200 
O103 0.54860 0.49000 0.25810 0.55870 0.12220 
O103 0.51470 0.02060 0.20920 0.58600 0.23530 
O103 0.59220 0.16650 0.15770 0.57030 0.20090 
O103 0.56400 0.22380 0.23520 0.61010 0.23530 
O113 0.24190 0.37020 0.07460 0.23980 0.04210 
O113 0.53180 0.37270 0.06910 0.61590 0.23000 
O113 0.56020 0.31600 0.22420 0.27870 0.03650 
O113 0.51360 0.00680 0.06470 0.44300 0.09550 
O113 0.58190 0.10410 0.08990 0.53630 0.12390 
O113 0.46860 0.15190 0.19030 0.50440 0.27440 
O114 0.48150 0.60580 0.35310 0.26890 0.04440 
O114 0.54380 0.44830 0.14740 0.30510 0.03790 
O114  0.58860 0.00390 0.06180 0.58290 0.20080 
O114  0.54410 0.09650 0.04430 0.63040 0.23650 
O114  0.56340 0.18790 0.16000 0.65410 0.12840 
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Appendix 14: PSS for LifeForce Formula 
  
 
 
 
 
 
LIFEFORCE FORMULA 
Product Specifications 
 
Product Description 
LIFEFORCE FORMULA is a yeast culture and trace mineral pak for all classes of equine. 
 
 
 
Label Information 
Guaranteed analysis    Ingredients 
Zinc min. 2110 ppm Corn distillers dried grains with solubles, Hydrolyzed yeast, 
Saccharomyces cerevisiae yeast culture, Zinc proteinate, 
Selenium yeast, Copper proteinate, Manganese proteinate. 
 
Copper min. 530 ppm 
Manganese min. 350 ppm 
Selenium min. 17.60 ppm 
 
 
 
 
Physical Characteristics 
Appearance: LIFEFORCE FORMULA is a medium brown powder with no discernible odor.  
Bulk Density:  to be determined 
 
 
 
 
 
Storage and Shelf Life 
LIFEFORCE FORMULA contains yeast and should be stored in a cool, dry place.  Open containers should be resealed.  Shelf life 
under these conditions is 18 months. 
 
 
 
 
Packaging 
LIFEFORCE FORMULA is available in 11.0 lb (5 kg) pails and 3.74 lb (1.7 kg) pouches. 
 
 
 
 
Directions for Use 
Provide two scoops of LIFEFORCE FORMULA to the daily diet.  
1 scoop = 1 oz 
 
 
 
 
 
 
 
 
ALLTECH INC. 
3031 Catnip Hill Pike Nicholasville, KY 40356 (859) 885-9613 Fax: (859) 885-6736 
LIFEFORCE FORMULA/Revised 11/13AJ     VER 3 
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Appendix 15:  Frozen Flow Data Scatterplot Examples 
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Merocyanine 540/YoPro 
 
 
FITC PNA/PI 
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